World Health Summit Berlin, Germany & Digital October

SCIENCE · INNOVATION · POLICIES

WORLD HEALTH SUMMIT BERLIN, GERMANY & DIG ITAL OCTOBER 25–27, 2020 VENUE DIGITAL SOCIAL MEDIA

Kosmos, Karl-Marx-Allee 131a www.conference. #WHS2020 10243 Berlin, Germany worldhealthsummit.org/ www.twitter.com/worldhealthsmt Program/WHS2020 WIFI www.facebook.com/worldhealthsummit Network: WorldHealthSummit www.linkedin.com/company/worldhealthsummit Password: #WHS2020 www.worldhealthsummit.org www.youtube.com/user/WorldHealthSummit1

Lounge

SAAL 10 ASIA

SAAL 7 ELIZABETH BLACKWELL

Registration Speaker Center M8 SAAL 1 SAAL 6 Foyer Lounge RUDOLF VIRCHOW EUROPE Press Area Karl-Marx-Allee

Outdoor Meeting ROBERT KOCH Point SAAL 5 OCEANIA

SAAL 2 SAAL 4 AMERICA AFRICA WORLD HEALTH SUMMIT BERLIN, GERMANY & DIGITAL OCTOBER 25–27, 2020 SUNDAY | OCTOBER 25, 2020

SAAL 1 SAAL 6 SAAL 10 SAAL 2 SAAL 4 SAAL 5 RUDOLF VIRCHOW EUROPE ASIA AMERICA AFRICA OCEANIA PD 01 | Page 20 PD 01 | Page 20 PD 02 | Page 22 PD 03 | Page 24 WS 01 | Page 26 WS 02 | Page 28 11:00 – COVID-19 Driving Overﬂow PD 01 Developing Antibiotics Antimicrobial Digital COVID-19 Innovations to 12:30 Eectiveness for Children Resistance Pandemic Response Improve Pandemic and Eciency in to Achieve SDG 3 World Health Management Preparedness Healthcare Global Antibiotic Organization (WHO) Helmholtz Centre for Johnson & Johnson Siemens Healthineers AG Research & Development Infection Research (HZI) Partnership (GARDP)

12:30–14:00 Lunch Break

PD 04 | Page 30 PD 04 | Page 30 PD 05 | Page 32 PD 06 | Page 34 WS 03 | Page 36 WS 04 | Page 38 14:00 – Multilateral Public Overﬂow PD 04 Nursing in the time A Call to Action Universal Health Changes in Health 15:30 Health Partnerships of COVID-19 for Health Data Coverage Research during during the COVID-19 University of Governance Robert Bosch and after the Crisis Eastern Finland Fondation Botnar Foundation COVID-19 Era Alliance Berlin Institute of Health The Graduate Institute (BIH) of International and Charité–Universitäts- Development Studies medizin Berlin QUEST Center

15:30–16:00 Co£ee Break

PD 07 | Page 40 PD 07 | Page 40 PD 08 | Page 42 PD 09 | Page 44 WS 05 | Page 46 WS 06 | Page 48 16:00 – A Fast European Overﬂow PD 07 Bringing the COVID-19 Strong Partnerships Recoupling Societal Translation in the 17:30 Response to Pan- Epidemic under as a Determinant Wealth and Individual Times of COVID-19 demics using Data Control of Health Health Berlin Institute of Health and Joint Investments Charité–Universitäts- GHA–German Health Global Solutions Initiative (BIH) in Health medizin Berlin Alliance Sanoﬁ Max Planck Institute for UNAIDS Infection Biology UNITE

KEY 01 | Page 50 18:00 – Opening Ceremony 19:30 Alliance World Health Summit

Keynote¦ Panel Discussion¦ Workshop MONDAY | OCTOBER 26, 2020

SAAL 1 SAAL 6 SAAL 10 SAAL 2 SAAL 4 SAAL 5 RUDOLF VIRCHOW EUROPE ASIA AMERICA AFRICA OCEANIA

KEY 02 | Page 54 PD 10 | Page 56 PD 11 | Page 58 PD 12 | Page 60 WS 07 | Page 62 WS 08 | Page 64 9:00 – Achieving Health National Responses Climate Change Access to Sustainable Multi Stakeholder Pandemics and 10:30 for All through Digital to COVID-19 and Health NCD Treatment & Care Collaboration in Global Operationalizing Collaboration Alliance London School of Hygiene Boehringer Ingelheim Health Research One Health World Health Tehran University of & Tropical Medicine Pharma GmbH & Co.KG German Federal Ministry German Federal Ministry Organization (WHO) Medical Sciences (TUMS) (LSHTM) The Defeat-NCD of Education and for Economic Cooperation The George Washington Alliance Partnership Research (BMBF) and Development (BMZ) University, Milken Institute The Lancet One Health School of Public Health Commission

10:30–11:00 Co£ee Break KEY 03 | Page 66 PD 13 | Page 68 WS 09 | Page 70 WS 10 | Page 72 11:00 – Strengthening the Setting a Evidence-Based InfectControl— 12:30 Role of the European New Agenda for Decision-Making in Investing in the One Union in Global Health Women and Cancer Global Health Health Approach German Federal Ministry Roche German Alliance for German Federal Ministry of Health (BMG) Global Health Research of Education and Germany’s Presidency German Federal Ministry Research (BMBF) of the Council of the of Education and InfectControl European Union Research (BMBF) 12:30–14:00 Lunch Break PD 14 | Page 74 PD 15 | Page 76 12:30 – Climate Change Youth Perspectives 14:00 and Health on Health Association of Academies International Federation and Societies of Sciences of Medical Students’ in Asia (AASSA) Associations (IFMSA) Inter-American Network of Academies of Science InterAcademy Partnership (IAP) The Network of African Science Academies KEY 04 | Page 78 PD 16 | Page 80 WS 11 | Page 82 WS 12 | Page 84 14:00 – Pandemic Prepared- Radiation Therapy NTDs and Challenges Vaccination and 15:30 ness in the Age of as an Essential of the COVID-19 Crisis Transmission Control COVID-19 Component Association of Research- Leibniz Association Charité–Universitäts- of Cancer Control based Pharmaceutical Research Center medizin Berlin International Atomic Companies (vfa) Borstel– Leibniz Lung Foundation for Innovative Energy Agency (IAEA) Eberhard Karls University Center New Diagnostics (FIND) Varian Medical Systems Tuebingen London School of Hygiene German Network against & Tropical Medicine Neglected Tropical (LSHTM) Diseases (DNTDs) Alliance German Society for Tropical Medicine and International Health (DTG) University Hospital Tuebingen

15:30–16:00 Co£ee Break PD 17 | Page 86 PD 17 | Page 86 PD 18 | Page 88 PD 19 | Page 90 WS 13 | Page 92 WS 14 | Page 94 16:00 – Perspectives from the Overﬂow PD 17 Climate Change Essential Surgical and ‘Building Back Better’ Overcoming Cultural 18:30 COVID-19 Pandemic and One Health Trauma Care with Smart Invest- Barriers through International Federation German National AO Alliance Foundation ments in NCDs Respect and Dialogue of Pharmaceutical Academy of Sciences Program in Global NCD Alliance InterAcademy Manufacturers & Leopoldina Surgery and Social Sanoﬁ Partnership (IAP) Asso ciations (IFPMA) InterAcademy Partnership Change of the Harvard Alliance The Lancet One Health Medical School Commission TUESDAY | OCTOBER 27, 2020

SAAL 1 SAAL 6 SAAL 10 SAAL 2 SAAL 4 SAAL 5 RUDOLF VIRCHOW EUROPE ASIA AMERICA AFRICA OCEANIA PD 20 | Page 98 PD 20 | Page 98 PD 21 | Page 100 PD 22 | Page 102 WS 15 | Page 104 WS 16 | Page 106 9:00 – COVID 50/50: Women Overﬂow PD 20 Decade of Action: Access to Essential Cardiovascular Health Developing Strategies 10:30 Leading in Crisis Accelerating Progress Medicines in LMICs Max Delbrück Center for Fighting COVID-19 Women in Global Health on the Health-Related Medicines Patent Pool for Molecular Medicine Around the World SDGs at Country Level (MPP) (MDC) (Part 1) German Federal Ministry German Federal Ministry of Health (BMG) for Economic Cooperation World Health and Development Organization (WHO) (BMZ)

10:30–11:00 Co£ee Break

PD 23 | Page 108 PD 23 | Page 108 PD 24 | Page 110 PD 25 | Page 112 WS 17 | Page 114 WS 18 | Page 116 11:00 – GOARN 2020: Overﬂow PD 23 Migrant and Refugee Women’s Health Fighting Falsiﬁed Developing Strategies 12:30 Changing the Face of Health in the COVID-19 Era and Substandard for Fighting COVID-19 Outbreak Support Alliance Charité–Universitäts- Medicines during Around the World Global Outbreak Alert Sapienza University medizin Berlin the COVID-19 Crisis (Part 2) and Response Network of Rome Alliance Association of Research- German Federal Ministry (GOARN) based Pharmaceutical for Economic Cooperation Robert Koch Institute Companies (vfa) and Development (RKI) German Federal Ministry (BMZ) World Health for Economic A£airs Organization (WHO) and Energy (BMWi)

12:30–14:00 Lunch Break

PD 26 | Page 118 PD 26 | Page 118 13:00 – BMJ Collection— Overﬂow PD 26 13:30 Women’s Health and Gender Inequalities KEY 05 | Page 120 PD 27 | Page 122 WS 19 | Page 124 WS 20 | Page 126 14:00 – Partnership Digital Health & AI A European Union New Voices 15:30 for the Goals for Pandemic in Health in Global Health German Federal Ministry Preparedness Charité–Universitäts- Global Young Academy of Health (BMG) Global He@lth 2030 medizin Berlin (GYA) World Health Innovation Task Force Alliance Organization (WHO)

15:30–16:00 Co£ee Break

KEY 06 | Page 128 16:00 – Accelerating the 17:30 SDG 3 Global Action Plan for Health and Well-being German Federal Ministry of Health (BMG) World Health Organization (WHO)

Keynote¦ Panel Discussion¦ Workshop TABLE OF CONTENTS 5

Welcome Messages¬6 • High Patrons of the World Health Summit¦6 • World Health Summit Presidents¦12 • Charité–Universitätsmedizin Berlin¦13

About the World Health Summit¦14

About the M8 Alliance¦15

Central Topics 2020¦16

Program¬19 • Sunday, October 25¦19 • Monday, October 26¦53 • Tuesday, October 27¦97

General Information¦131 • Good to Know¦132 • City of Berlin¦134 • World Health Summit Leadership¦136 • M8 Alliance Leadership¦140 • Speakers Index¦143 • Institutions Index¦146 • Partners¦148 • World Health Summit O±ce¦153 • Imprint¦156 6 WELCOME MESSAGES HIGH PATRONS OF THE WORLD HEALTH SUMMIT

search, development and produc- also to ensure their fair distribution tion capacities in Germany but also as well as that of suitable drugs to support the Coalition for Epi- and diagnostic tests. I will continue demic Preparedness Inno vations— to call for the largest possible an international coalition made up number of international partners of public and private partners. to support this helpful initiative.

Together we must, above all, turn Coronavirus knows no borders. our attention to those countries The necessary global response must Coronavirus has confronted us which have been hit particularly therefore not fail due to national with a huge challenge on a global severely by the pan demic—coun- borders. The key to containing and scale. The unprecedented mag - tries with a high population den- overcoming the pandemic can only nitude of the health, humanitarian sity, extreme poverty and over- be found in international coopera- and economic e£ects requires an burdened health systems. People tion and coordination. That is why unprecedented measure of coop- su£ering from underlying health I am deeply grateful to you for eration to deal with the pandemic. problems, hunger or malnutrition con tributing your expertise to the Numerous experts, engaged in as well as those with no access to World Health Summit, exchanging an in-depth exchange of views on safe drinking water have a higher ﬁndings and drawing up recom- this extraordinary challenge at this risk of becoming infected and mendations. I wish you all the best, year’s World Health Summit, are seriously ill. Wherever they are and above all of course, that you making an enormous contribution in the world—we must not leave stay healthy. towards this. For that I am deeply them to cope alone. grateful and I would like to warmly welcome you to Berlin. Germany would like to live up to its international responsibility by Angela Merkel The German Government is doing adopting a comprehensive and Chancellor of the everything in its power to ensure coherent approach. That is why Federal Republic of Germany that a safe and e£ective vaccine we are cooperating with the WHO, can be made available as quickly the European Commission and as possible in Germany, in Europe other international partners, among and around the world. We have other things to further the Access provided a substantial level of to COVID-19 Tools Accelerator. funding for this. This is not only The aim of this multilateral platform enabling us to expand the reis not only to develop vaccines but WELCOME MESSAGES 7 HIGH PATRONS OF THE WORLD HEALTH SUMMIT

and the world’s best experts to capacities to anti cipate and react present their analyses, their knowl- to crises. The WHO is the only edge and to discuss their opinions. world organi zation capable of I am delighted that this session carrying out this mission; it is gives us a particular opportunity to crucial that we reinforce it for the bring to light our European vision, future, as a new emerging virus at a time when Europe is strength- might a£ect the human popula- ening its health agenda, under the tion. France has stepped up its German presidency of the Euro- support to WHO, and to the WHO The year 2020 will go down in the pean Union. Academy, which is essential to history of all nations as a memora- provide training resources world- ble year due to the shock of the The World Health Summit has made wide, particularly in times of crisis. unprecedented Covid-19 pandemic us understand that the scientific that we have collectively faced. world can help us make better The multilateral response to the As the World Health Summit begins decisions on global health. I call Covid-19 crisis was unprecedented. in Berlin and around the world via here for a global health policy that In March, world leaders gave a our screens, more than one million are based on the latest scientific mandate to WHO to coordi nate people have died, and the pan demic knowledge, that can be shared and the response, and within weeks the is still active. proved accurate by peer review. Access to Covid-19 tools accelerator (ACT-A) was launched. France, In this new context, internatio nal We have been working—we nations, Germany, the European Union, forces have divided, concerted, and international orga ni zations, founda- as well as many other States and cooperated. The world-renowned tions, and experts—to learn more donors were at the heart of this World Health Summit gives us a about the COVID-19 pandemic. initiative and endowed it with great opportunity to bring together The World Health Organisation significant resources. ACT-A is a capable people of good will, in (WHO), as the leading organi zation novel ap proach, led by a consor- order to find solutions to this crisis. in health, has played a key role, tium of international health actors, consolidating and providing epide- WHO, the Global Fund to Fight I would like to thank my friend miological analysis for the world. AIDS, Tuberculosis and Malaria, and outstanding leader Chancellor the GAVI Vaccine Alliance, Unitaid Angela Merkel, to o£er once again France has supported the WHO and the World Bank have pooled her High Patronage, as well as and is contributing, along with their resources to find practical Professor Ganten’s dynamic or - Germany, to multilateral reflections solutions to provide the world with ganisation for allowing specialists on strengthening and im proving its diagnostics, treatments and vac- 8 WELCOME MESSAGES HIGH PATRONS OF THE WORLD HEALTH SUMMIT

cines and to increase the capacity diversity on human health. Our health of all people without leaving to distribute products worldwide. generation needs to protect those anyone behind. Women’s health Much has been done and more is who are ahead of us and those will be an area for action support- to come. who follow us. ed by France in view the Genera- tion Equality Forum in 2021. Once the vaccine is found, it will be Together with our closest partners, a global public good. That means such as Germany, France is keen I hope this 12th session of the that it will have to be proved safe to bring the “One Health” agenda World Health Summit year will and e±cient according to scientific to the fore, promoting further be as thought provoking as the and regulating authorities, acces- inte gra tion of sustainable devel- previous session and even more, sible to all who need it, in all coun- opment goals cross sectorial considering the extraordinary tries. It must be equitably distrib- scienti fical knowledge. challenges of the time. uted around the world on ethical principles, prioritising vulnerable This year, in which global health populations and health workers. has been at the forefront of our priorities, has confirmed the analy- France is also very keen to high - ses we have been making for a light the interaction between hu- long time: the social determinants man, animal and planetary health. of disease are of great importance Emmanuel Macron Science will provide us with clear and women and vulnerable popu- President of the Republic of France ways.The Covid-19 crisis has been lations are the first and hardest hit. a re vealing event and har binger of a new world, as we have wit- As the global public health com- nessed the direct e£ects of bio- munity, we must safeguard the WELCOME MESSAGES 9 HIGH PATRONS OF THE WORLD HEALTH SUMMIT

sionals amongst many others to and take more responsibility in the work around the clock to under- health sector. stand the virus, its progression to cause disease, and to develop The third lesson is that when viruses vaccines and therapeutics. But also go global, we need immediate global to inform health policies and guid- action to bring global solutions. Some ance for our citizens, economies very positive strides are being made: and societies. we raised nearly €16 billion under the Coronavirus Global Response This twelfth edition of the World The EU invested €459 million in through a global call for action. No Health Summit is anything but grants for 103 new research projects, country in the world, no Union is business as usual. With all conti- and by the end of 2020, the EU will large and strong enough to address nents hit by COVID-19 in 2020, this invest €1 billion into research and these challenges on their own. This World Health Summit is the first innovation to tackle COVID-19. We is why the position of the European one since the World Health Organ- are investing heavily in research and Commission is clear: we want to ization has characterized this virus innovation but also in our Vaccines promote multilateral cooperation as a pandemic. Strategy to boost production capac- and improve and reform the World ity of companies who will supply Health Organization to make it ready From all over the world, health vaccines for both EU and non-EU to face the health challenges of the experts and leaders are gathering countries. twenty-first century, for the benefit this year again in Berlin to draw of everyone on every continent. the lessons and consequences of Second, we need to be collectively this pandemic. There is so much much better prepared for future We have all felt the impact of this to be learnt and shared. health challenges. We do not want pandemic in some form, and we to experience again shortages of can and we are coming together First, this pandemic has reminded personal protective equipment, to overcome this terrible disease. us that health truly is multidimen- intensive care units overflowing, I wish each of you a healthy summit sional: a new virus, which no one and healthcare professionals strug- as well as an inspiring learning had heard of this time last year, gling to cope with the excessive experience. created a butterfly e£ect of vast demands. Global challenges asso- outreaching health challenges ciated with the climate, trade and spanning the globe. It required the health will continue to bring new coming together of many scientists, and emerging global health chal- Ursula von der Leyen researchers, and medical profes- lenges. The EU is ready to step up President of the European Commission 10 WELCOME MESSAGES HIGH PATRONS OF THE WORLD HEALTH SUMMIT

It has never been clearer that health catalyse the development and is a political and economic choice. equitable distribution of vaccines, In the past 20 years, countries have diagnostics and therapeutics. invested heavily in preparing for terrorist attacks, but relatively little Yet, even as we marshal our forces in preparing for the attack of a to bring this pandemic to an end, virus—which, as the pandemic has we must also work with equal proven, can be far more deadly, urgency to strengthen our health disruptive, and costly. systems and public health infrastructure so that the world is never The COVID-19 pandemic has dis - Thanks to advances in biology, again blindsided by a health emer- rupted our world. The manner in science and technology, we have gency. A strong health system is which we conduct ourselves during been able to greatly accelerate a resilient health system. this crisis, whether we learn lessons the research and development for from it, and how we chose to build vaccines, diagnostics and thera- The lessons so far are clear. back better, is up to us. peutics for COVID-19. No disease in history has benefited from such The first is that health is not a Since the novel coronavirus took rapid research. luxury item for those who can hold more than nine month ago, a£ord it; it is a necessity, a human lives and livelihoods have been lost But the greatest challenge we face right and the foundation of social, and economies and societies have now is not scientific or technical. economic and political stability. been upended. The pandemic has We face a test of our character. The second is that there has never exposed and exploited our political Can countries come together in been a greater need for global fault lines and inequalities, and solidarity to share the fruits of cooperation and to confront a the gaps in our health systems. research? Or will misguided natio- global threat. A coherent interna- The impacts go far beyond the nalism hobble our response? tional response is key. su£ering caused by the virus itself, with major disruptions to services In April, WHO, the European Com- And the third is that the time to for global hunger, immunization, mission and multiple other part- prepare for emergencies is before noncommunicable diseases, family ners launched The Access to they occur. COVID-19 has demon- planning and more. COVID-19 Tools Accelerator, to strated that the world was not WELCOME MESSAGES 11 HIGH PATRONS OF THE WORLD HEALTH SUMMIT

pre pared. Even some of the most and other health emergencies is advanced societies and economies a strong health system, built on have been overwhelmed. While primary health care with an em- many countries put enormous re- phasis on promoting health and sources into sophisticated medical preventing disease. care, too many also neglect their basic public health systems.We are That’s why WHO’s top three pri- paying the price for that now. orities are healthier populations, universal health coverage and Investments in disease surveillance health security. and monitoring, health promotion, water, sanitation and hygiene, edu- This will not be the last pandemic cating and empowering communi- or global health emergency we will ties and building a strong health face. When the next one comes, workforce are essential for building the world must be ready. Part of resilient public health systems. every country’s commitment to build back better must therefore The absence of any one of these be to public health, as an invest- leaves communities vulnerable and ment in a healthier and safer undermines the timely response future. necessary to contain outbreaks. My best wishes for a productive Some countries are already show- and inspiring Summit. ing the way. The German Chancel- lor, Angela Merkel, has announced that Germany will invest €4 billion by 2026 to strengthen its public Tedros Adhanom Ghebreyesus health system. Director-General of the World Health Organization (WHO) Ultimately, the best defence against the impact of outbreaks 1212 WELCOME MESSAGE WORLD HEALTH SUMMIT PRESIDENTS

minants, outbreaks and to protect and support the most vulnerable. Their work needs the support of decision makers at the highest level. We therefore strongly support the important role of the WHO.

Reﬂecting on these past months of living with the COVID-19 pandemic, we are hopeful that this global Charles Ibingira Detlev Ganten health crisis emphasizes the essential nature of international, multilateral cooperation and will lead to the WELCOME TO THE strengthening of multinational structures and organizations. Because viruses, infectious diseases, or other WORLD HEALTH SUMMIT 2020 health threats, know no borders. The World Health Summit and the M8 Alliance provide The spread of COVID-19 this year shows how essential an ever more important forum for science, industry, the improvement of global health is and how crucial the civil society and politics. We are excited to welcome strengthening of international and interdisciplinary so many diverse speakers from di£erent organizations cooperation remains. who contribute tremendously to advancing science A meeting like the World Health Summit with our strong and educating the public. An educated public is more partners, especially also the WHO, could not be more important than ever in this unprecedented health crisis important in these days. to understand the voice of science and to understand

the necessary measures to curb the spread of COVID-19. The COVID-19 epidemic has catapulted global health into the political focus. It has also reinforced the con- We look forward to your participation at the World sistent message of the Word Health Summit and our Health Summit 2020—in Berlin or online. academic backbone, the M8 Alliance, that progress Please remain healthy and keep safe. in global health is based on political choices and the application of strong policy-making instruments of governments and international institutions worldwide.

The World Health Summit brings together stakeholders from around the globe to engage in solutions. We con- Charles Ibingira Detlev Ganten sider strong and reliable governance—at global, national International President 2020 Founding President and local levels—essential for health and wellbeing. The World Health Summit World Health Summit world needs strong institutions to set norms and stand- Principal, Makerere University ards to be able to respond e£ectively to health deter- College of Health Sciences, Uganda WELCOME MESSAGE 13 CHARITÉ – UNIVERSITÄTSMEDIZIN BERLIN

For the ﬁrst time, the event will take place as an on- site event and digital conference, thus enabling the more than ever important exchange and cooperation between nations to improve global health. 2020 has been shaped both by the corona pandemic and activities and discussions on climate change. We live in times of uncertainty, false reports and hostility, but also Heyo Kroemer Axel Radlach Pries in times of hope, commitment and networking. Let us take this opportunity to contribute to education and DEAR WORLD HEALTH SUMMIT knowledge exchange, to strengthen prevention and PARTICIPANTS health promotion, and to develop a variety of sustainability options.

2020 is a remarkable year, and we are all the more As Charité, we are proud of the World Health Summit, pleased to welcome you at this year’s World Health the associated exchange and the work of the M8 Alliance Summit. —the academic backbone of the World Health Summit. We thank you for your interest, your work and your Charité–Universitätsmedizin Berlin looks back on a commitment. Let us work together to make the world history of more than 300 years and, as the largest a healthier place. university hospital in Europe, it stands for excellent patient care and research, practice-oriented teaching We wish you an interesting and exciting World Health and innovative developments. One of the most success- Summit. Stay healthy. ful initiatives was the founding of the World Health Summit from within Charité, and now—12 years later— we proudly look at one of the world’s largest health conferences, which brings together experts from more than 100 countries every year.

Heyo Kroemer Axel Radlach Pries Chief Executive O±cer Dean Charité – Universitätsmedizin Charité – Universitätsmedizin Berlin Berlin 14 ABOUT THE WORLD HEALTH SUMMIT

SCIENCE – INNOVATION – POLICIES

The World Health Summit is one of the world’s leading The mission of the World Health Summit is to improve strategic forums for global health. Held annually in health worldwide by: Berlin, it brings together leaders from politics, science • Bringing together all stakeholders and medicine, the private sector, and civil society to set • Facilitating constructive exchange in an environment the agenda for a healthier future. Speakers and parti- of academic freedom cipants from all over the world include: • Finding answers to major health challenges • Leading scientists and medical professionals • Making global recommendations and setting health • Ministers and civil servants agendas • High-ranking o±cials at international organizations The World Health Summit was founded in 2009, on the • CEOs from industry and civil society occasion of the 300th anniversary of Charité. • Young professionals and students www.worldhealthsummit.org ABOUT THE M8 ALLIANCE 15

The “M8 Alliance of Academic Health Centers, makers to develop science-based solutions to health Uni versities and National Academies” is the academic challenges worldwide. foundation of the World Health Summit. The Inter- national Presidency of the World Health Summit rotates The M8 Alliance organizes annual Regional Meetings, annually among the members of the M8 Alliance. regular Expert Meetings, and Summer Schools. As a It is a growing network and currently consists of 28 result of each World Health Summit the M8 Alliance members in 19 countries, including the InterAcademy issues the M8 Declaration: recommendations for action Partnership, which represents the national academies to international policymakers. of medicine and science in 130 countries. The M8 Alliance was initiated by Charité–Universitäts- All members are committed to improving global health medizin Berlin in 2009 on the occasion of the ﬁrst and working with political and economic decision- World Health Summit.

Tehran University of Medical Sciences

Tehran University of Medical Sciences (TUMS) is accredited with premier status by the Accreditation Service for International Colleges (ASIC). ASIC is recognized by the United Kingdom Department for Education and Skills (DfES), the United Kingdom Department for Universities, Innovation and Skills (DUIS), the United Kingdom Border and Immigration Agency (Home Oﬃce), the United Kingdom Oﬃce for Standards in Education (Ofsted). ASIC is a member of Council for Higher Education Accreditation (CHEA). 16 CENTRAL TOPICS 2020

Pandemic Preparedness in the Age of COVID-19: Climate Change and Health: Global Cooperation not Competition Risks and Responses The COVID-19 pandemic has once again shown that Unprecedented changes are occurring in natural sys- we need everyone to get involved in a massive e£ort tems that threaten to undermine progress in human to keep the world safe. Researchers are working at high health. Sustained population health requires the life- speed to understand new viruses, develop treatments supporting “services” of natural systems. Populations and vaccines to curb pandemics and prevent future of all animal species depend on supplies of food and outbreaks. With COVID-19 new forms of collaboration water, low exposure to major infectious diseases, and have emerged for scientists around the world to share a stable climate. Urgent action is needed to reduce results much faster than during any previous outbreaks. the greenhouse gas emissions leading to rapid climate With leadership by the World Health Organization change and to address other environmental trends (WHO), science has to take a collective and non-dis- that pose increasing health risks. criminative responsibility to support such a global governance. Partnership for the Goals: United Nations’ 75th Anniversary Strengthening the Role of the European Union Achieving the Sustainable Development Goals, our in Global Health shared vision for the future, will require cooperation In recent years, Germany has strengthened its com- across borders, sectors, and generations. But just when mitment to global health, leveraging its G7 and G20 we need collective action more than ever, support for presidencies and lending support to multilateral and global cooperation is ﬂagging. In many countries, public bilateral health partnerships. It has also become one trust in traditional institutions is in decline and relations of the strongest supporters of the World Health Organ- between countries are under strain. Dialogue and action ization and other international agencies. Germany has on global issues—nearly all of which directly and indirect- announced that global health will be a priority during ly a£ect health—could not be more urgent. Through its 2020 EU presidency, in cooperation with its trio- these conversations, the UN aims to build a global vision partners Portugal and Slovenia. This presents a sig- of 2045 (its centenary), increase understanding of the niﬁcant opportunity to help identify interventions in threats to that future, and support enhanced interna- areas like development, health, research, environment, tional cooperation to realize that vision. and trade that all EU members can implement to achieve SDG 3.

CENTRAL TOPICS 2020 17

Accelerating the SDG 3 Global Action Plan Digital Health & AI for Pandemic Preparedness for Health and Well-Being Following the ﬁrst meeting of world leaders on universal The Global Action Plan for Healthy Lives and Well-Being health coverage (UHC) and launch of the Global Action for All brings together 12 multilateral health, develop- Plan for Healthy Lives and Well-Being for All at the UN ment, and humanitarian agencies to better support General Assembly in 2019, as well as the WHO Director- countries and accelerate progress towards health-relat - General 2020 “Global Strategy on Digital Health,” the ed Sustainable Development Goals. Under the Global stakes for advancing a truly global market in digital Action Plan, the agencies are better aligning their work health have taken on a new dimension. The next step is to reduce ine±ciencies and provide more streamlined ensuring a transformative and multi-stakeholder eco - support to countries and forums for international com- system for the sustainability of innovations and growth mitments to health, such as the UN High-Level Meeting of digital public goods, their economic viability, scale- on Universal Health Coverage and the Astana Con - up, and inclusivity. ference on Primary Health Care. At the World Health Summit, representatives of the signatory agencies will present updates on the Action Plan, and its challenges and successes.

Translational Research: Advancing Innovative Treatments Translational research is part of a bidirectional process in which research findings are moved from the researcher’s bench to the patient’s bedside, but also back from clinical findings into mechanistic research. Development of new diagnostic and informatics methods has seen a trend towards more personalized therapeutic approaches. Information on individuals’ genomic/transcriptomic profiles, in combination with lifestyle and environmental factors, are integrated to guide medical decisions in terms of prevention, diagnosis, and treatment of disease.

18 PROGRAM

SUNDAY, OCTOBER 25 20 SUNDAY, OCTOBER 25

PANEL DISCUSSION

PD 01 COVID-19 DRIVING EFFECTIVENESS Live | SAAL 1 AND EFFICIENCY IN HEALTHCARE RUDOLF VIRCHOW Overﬂow | SAAL 6 EUROPE

11:00 – 12:30 HOST

Siemens Healthineers AG

Healthcare needs to become more But Healthcare it is not only about speed accessible and a£ordable for patients. and e±ciency—we are touching human Digitalization and best practices from health and we are dealing with sensitive other sectors will facilitate this transfor- personal information. While taking the mation. This transformation of Healthcare opportunities, we have to strike the right has been a topic before the COVID-19 balance and protect the integrity of the pandemic. COVID-19 however has forced individual. The worldwide pandemic us to become more flexible and find new has turned the focus of policy makers to ways to deliver healthcare. The speed healthcare topics in an unprecedented and flexibility of Healthcare providers, manner and has shown to every person legislators, authorities and industry has that individual interests and the common been impressive and inspiring. It has interest have to be weighed against each shown us what can be achieved if there other for the benefit of all. is imminent need and a common goal. PROGRAM 21

CHAIR

Dagmar Mundani Siemens Healthineers AG | Compliance and ECC | General Counsel and Head of Healthcare Legal, Compliance and ECC | Germany Ricardo Ulrich

Baptista Leite Dirnagl PROGRAM, SUN 25

SPEAKERS

Ricardo Baptista Leite Bart de Witte UNITE | Founder and President | HIPPO AI Foundation and Portugal Health Academy | Founder | Germany Alena Buyx

TUM School of Medicine | Ulrich Dirnagl Alena Dagmar Professor of Ethics in Medicine Charité–Universitätsmedizin Berlin | Buyx Mundani and Health Technologies | Department of Experimental Neurology | Germany Director of the Department | Germany Francesca Colombo Organization for Economic Cooperation Michael Neumaier and Development (OECD) | Heidelberg University | Head of the Health Division | Institute for Clinical Chemistry |

France Director of the Institute | Francesca Michael Germany Colombo Neumaier

Bart de Witte 22 SUNDAY, OCTOBER 25

PANEL DISCUSSION

PD 02 DEVELOPING ANTIBIOTICS

SAAL 10 | ASIA FOR CHILDREN TO ACHIEVE SDG 3 11:00 – 12:30

HOST

Global Antibiotic Research & Development Partnership (GARDP)

Sepsis, a complication of infection plans to evaluate new antibiotics for use encompassing bloodstream infections, in children, these are often not started meningitis and pneumonia, is the third until after drugs are registered for use most common cause of death among in adults. A recent study found that of newborns, accounting for 225,000 37 antibiotics being developed in adults, deaths globally every year. The World just two were being studied in children. Health Organization has called for urgent action to accelerate the development Addressing the challenge of developing of new antibiotics for bacterial infections, new and expanded access to urgently including sepsis, alongside expanded needed antibiotics for children under 5 access to antibiotics for newborns and cannot be solved by one country, com- children, in order to facilitate achievement pany or organization alone. It can only be of Sustainable Development Goal 3: addressed through a global and multi- Health and Wellbeing for All. sectorial approach. Partnerships between governments, industry, academia and civil Children and newborns are not small society are needed to ensure plans are adults and their bodies may respond developed and resources are optimized di£erently to drugs. It is critical to estab- to accelerate antibiotic research, develop- lish the correct dose and conﬁrm safety ment and access for children. and e£ectiveness of new and currently available treatments for children under 5. Within this session, the panel will discuss Although regulatory agencies require the unique challenges of antibiotic re - pharmaceutical companies to develop search focusing on children and newborns. PROGRAM 23

This will include the progress being expanded access to treatments for made, and further action required to children and newborns to achieve SDG 3 develop new treatments and ensure and the Every Newborn Action Plan.

CHAIR Nicholas Elmar

Adomakoh Nimmesgern PROGRAM, SUN 25 Claire Doole Doole Communications | Coach, Trainer, Moderator | Switzerland

SPEAKERS

Manica Balasegaram Dagmar Reitenbach Global Antibiotic Research & Federal Ministry of Health | Development Partnership (GARDP) | Head of Division Global Health | Director | Germany Switzerland Sithembiso Velaphi Alex Costa Chris Hani Baragwanath Academic Alex Sithembiso UNICEF | Global HIV/AIDS Program | Hospital | Associate Professor Costa Velaphi HIV/AIDS Specialist University of the Witwatersrand and Head of Paediatrics | Elmar Nimmesgern South Africa Global AMR R&D Hub | Secretariat Lead | Germany

Claire Doole 24 SUNDAY, OCTOBER 25

PANEL DISCUSSION

PD 03 ANTIMICROBIAL RESISTANCE How to Solve the Issue of Shortages of Existing Antibiotics SAAL 2 | AMERICA and Preserve the Environment from Discharges 11:00 – 12:30

HOST

World Health Organization (WHO)

Past years have seen a growing attention Current antibiotic producers in Europe towards antimicrobial resistance that keep closing manufacturing facilities for led to a number of new initiatives in finished products and active pharmaceu- particular to foster the development of tical ingredients. Procurement practices new antibacterial treatments. In parallel, that are driving prices down combined another problem is surging and getting with fierce competition with companies increasing public attention: the lack of from India and manufacturers in China supply of existing generic antibiotics. and relatively high production standards Many hospitals even in developed coun- and costs in Europe are some reasons tries are facing di±culties in ensuring a behind this trend. steady supply of critical first line treatments, in particular injectable antibiotics This session is going to shed light on preventing doctors from using the recom- the challenges and the risks and possible mended antibiotics and increasing costs. solutions to keep a steady supply of existing generic antibiotics and will link The problem has increased exponentially this issue to the conditions under which over the past years in many countries. these products are produced. PROGRAM 25

CHAIR

Peter Beyer World Health Organization (WHO) | Senior Advisor

SPEAKERS Peter Joakim Beyer Larsson PROGRAM, SUN 25 Steve Brooks Joakim Larsson AMR Industry Alliance | Advisor | University of Gothenburg | Switzerland Interdisciplinary Centre for Antibiotic Resistance Research | Director | Dame Sally Davies Sweden UK Government | Department of Health and Social Care | Special Envoy Céline Pulcini on Antimicrobial Resistance | Ministry for Solidarity and Health | Steve Céline United Kingdom Antimicrobial Resistance Brooks Pulcini National Action Plan Coordinator | Thomas Garms France Asklepios Kliniken GmbH | Pharmacist | Germany

Dame Sally Davies 26 SUNDAY, OCTOBER 25

WORKSHOP

WS 01 DIGITAL COVID-19 PANDEMIC

SAAL 4 | AFRICA RESPONSE MANAGEMENT 11:00 – 12:30 SORMAS for COVID-19 Response Across the Globe

HOST

Helmholtz Centre for Infection Research (HZI)

The COVID-19 pandemic has led to an The aim of this session is to have front exponential increase in demand and line health o±cers, coordinators, stake- application of SORMAS for the digital holders and researchers from ﬁve dif- integration of surveillance, laboratory ferent regions of the world share their diagnostics and contact person follow- experience in the development, deploy- up, isolation and quarantine measures. ment and application of SORMAS for The digital and mobile SORMAS (Sur- the ﬁght against COVID-19. Furthermore, veillance Outbreak Response Manage- the session aims to establish strategies ment and Analysis System) has not for using the current momentum towards only experienced a rapid expansion establishing a sustainable and compre- geographically but also a technological hensive digital integration of surveillance boost with respect to global goods and epidemic response beyond COVID-19. maturity, scalability and novel informa - A major component of this will be to tion technologies (www.sormas.org). guide the transition from project mode toward a program mode of SORMAS and to develop sustainable open source business models compatible with global public health demands. PROGRAM 27

CHAIR

Gérard Krause Helmholtz Centre for Infection Research (HZI) | Department for Epidemiology | Head | Germany Gérard Dagmar

Krause Starke PROGRAM, SUN 25

SPEAKERS

WORKSHOP

WS 02 INNOVATIONS TO IMPROVE

SAAL 5 | OCEANIA PANDEMIC PREPAREDNESS 11:00 – 12:30 How to Develop the Right Tools, at the Right Time

HOST

Johnson & Johnson

Diagnostics, vaccines and treatments research funding to combat this novel are critical tools to monitor and halt an pathogen. What are the learnings from epidemic, in addition to adequate pro- the scientiﬁc response to COVID-19? duction capabilities and equitable access How can we strengthen cross-sector and delivery of these tools. When the partnerships for innovation against viral sequence of COVID-19 became emerging health security threats? available, scientists from both the private How to distribute treatments and sector and academia immediately began vaccines? What mechanisms should the search for vaccines and treatments, be in place to accelerate the develop - mobilizing resources and forming part- ment new tools and technologies nerships to spur innovation. Governments to protect global health security? around the world have announced PROGRAM 29

CHAIR

Sabine Campe Open Consultants | Managing Director | Germany

SPEAKERS Catharina Paul Boehme Sto£els PROGRAM, SUN 25 Catharina Boehme Veronika von Messling Foundation for Innovative Federal Ministry of Education New Diagnostics (FIND) | CEO | and Research (BMBF) | Switzerland Life Sciences Division | Director-General | Germany Jayasree K. Iyer Access to Medicine Foundation | Sir Andrew Witty Executive Director | World Health Organization Special Envoy Sabine Veronika The Netherlands to the ACT-Accelerator Campe von Messling

Paul Stoels Johnson & Johnson | Vice Chair of the Executive Committee and Chief Scientiﬁc O±cer | United States of America

Jayasree K. Sir Andrew Iyer Witty 30 SUNDAY, OCTOBER 25

PANEL DISCUSSION

PD 04 MULTILATERAL PUBLIC HEALTH Live | SAAL 1 PARTNERSHIPS DURING THE RUDOLF VIRCHOW Overﬂow | SAAL 6 COVID-19 CRISIS EUROPE

14:00 – 15:30 HOSTS

M8 Alliance

The Graduate Institute of International and Development Studies

Multilateral cooperation is central in a level. In many cases these reforms have pandemic. As the experiences in the followed on major disease outbreaks: COVID-19 pandemic show public health SARS, Ebola and now COVID-19. This institutions play a central role in both session will discuss the experiences preparedness and response at the national gained by centers of disease control level and through their international in China, Africa, the European Union, cooperation. Over the last decade new Germany and France—and how they centers for disease control have been have strengthened their cooperation established and existing centers have to support global health and what still been strengthened, including at regional remains to be done. PROGRAM 31

CHAIR

Ilona Kickbusch The Graduate Institute of International and Development Studies | Global Health Center | Chair of the International Advisory Board | Switzerland Andrea John

Ammon Nkengasong PROGRAM, SUN 25

SPEAKERS

Andrea Ammon Stéphanie Seydoux European Centre for Disease Prevention Ministry for Europe and Foreign A£airs and Control (ECDC) | Director | (MEAE) | Ambassador for Global Health | Sweden France

George F. Gao Lothar H. Wieler George F. Stéphanie Chinese Center for Disease Control Robert Koch Institute (RKI) | President | Gao Seydoux and Prevention | Director | Germany China

John Nkengasong Africa Centres for Disease Control and Prevention | Director | Ethiopia

Ilona Lothar H. Kickbusch Wieler 32 SUNDAY, OCTOBER 25

PANEL DISCUSSION

PD 05 NURSING IN THE TIME

SAAL 10 | ASIA OF COVID-19 14:00 – 15:30

HOST

University of Eastern Finland

The World Health Organization desig- morale and ethics to the oppressed, nates 2020 as the International Year depressed, exploited, and deprived of the Nurse and Midwife. Nurses are vulnerable groups of the society. During considered the backbone of the health- pandemic times, nurses are involved care system comprising of at least 60% in planning, organizing, implementing, of the total global health workforce. and evaluating the e£ectiveness of the They are essential health workforce healthcare services using existing evi- in the attainment of the Universal Health dence-based practice. Coverage (UHC) and Sustainable De - velop ment Goals( SDGs). As the world Despite the evident role of nurses in succumbs from the pandemic case the social and healthcare system, their of COVID-19, nurses fulﬁll their duties visi bility in the decision and policy- in saving lives but remain undervalued making process is limited and are not in many countries. given the maximum potential to utilize their skills and competencies. For the past decade, the role of the nursing profession has long been proven What are the factors hindering the vital in the global health and pandemic advancement of nurses’ role during crisis such as Zika virus, Ebola virus and pandemic times? How can member the most recent Corona virus. They are states of the World Health Organization the frontline healthcare workers deliver- commit to promoting and protecting ing essential care based on the available the interests of nurses’ welfare and resources with the highest form of work health in a sustainable manner? PROGRAM 33

CHAIR

Floro Cubelo Filipino Nurses Association in the Nordic Region | President | Finland

SPEAKERS Jim Annette Campbell Kennedy PROGRAM, SUN 25 Jim Campbell Dame Donna Kinnair World Health Organization (WHO) | Royal College of Nursing | Director of Health CEO and General Secretary | Workforce Department United Kingdom

Elizabeth Iro Katri Vehviläinen-Julkunen World Health Organization (WHO) | University of Eastern Finland |

Chief Nursing O±cer Faculty of Health Sciences | Chair | Floro Dame Donna Finland Cubelo Kinnair Annette Kennedy International Council of Nurses (ICN) | President | Switzerland

Elizabeth Katri Iro Vehviläinen- Julkunen 34 SUNDAY, OCTOBER 25

PANEL DISCUSSION

PD 06 A CALL TO ACTION FOR

SAAL 2 | AMERICA HEALTH DATA GOVERNANCE 14:00 – 15:30

HOST

Fondation Botnar

The convergence of big health data— Fast-moving technological developments from diverse data types and a broad and the growing aspirations—by service range of personal, clinical, and environ- providers, donors, tech companies, health mental sources—with massive advances authorities, patients, consumers and many in information technology (IT) and artifi- others—to field these technologies on a cial intelligence (AI) o£ers unprecedent ed wide scale, however, lead to mounting opportunities for individual and public concerns over data protection, privacy, health. The comprehensive capturing and ownership. Yet, the majority of WHO and computational analysis of massive Member States still lack robust national amounts of health-relevant data allows data governance and digital health frame- for innovative applications in disease works, which could ensure that the new prevention, diagnostics, treatment, but technologies deliver sustained health also for more e±cient resource allocation, benefits while protecting informational remote training or pre-basic care, to rights. Investigating how data sharing and name just a few possibilities. Ultimately, use for research, commercial and public “frontier technologies” have the potential health purposes can be aligned with calls to radically transform the way health - for data protection, privacy, and infor- care is practiced—not only in a¾uent mational self-determination, the panel countries of the global north, but also discusses possible contours of a global in low-and middle-income countries. health data governance instrument. PROGRAM 35

CHAIR

Stefan Germann Fondation Botnar | CEO | Switzerland

SPEAKERS Stefan Bernd Germann Montag PROGRAM, SUN 25 Lawrence O. Gostin Päivi Sillanaukee Georgetown University | Ministry of Foreign A£airs | O’Neill Institute for National and Global Ambassador for Health and Wellbeing | Health Law | Director | Finland United States of America Ey Vayena Bernardo Mariano Jr. ETH Zurich | Professor of Bioethics,

World Health Organization (WHO) | Health Ethics and Policy Lab | Lawrence O. Päivi Department of Digital Health and Switzerland Gostin Sillanaukee Innovation | Director of the Department and the Chief Information O±cer

Bernd Montag Siemens Healthineers AG | President and CEO | Germany

Bernardo E£y Mariano Jr. Vayena 36 SUNDAY, OCTOBER 25

WORKSHOP

WS 03 UNIVERSAL HEALTH COVERAGE New Choices for Best Practices SAAL 4 | AFRICA 14:00 – 15:30

HOST

Robert Bosch Foundation

‘Universal Health Coverage’ is one aim of health, health promotion, and prevention Sustainable Development Goal 3 ‘Good building their basic fundament. Sustain- health for all’. This highly ambitious aim able health care structures will also adapt brings about a number of challenges that to regional needs to (re-)act appropriately were particularly laid open in the light of to geographical and social di£erences. the corona-crisis: accessibility of health Reliance on evidence about regional and care facilities, quality of care provision, population needs, on monitoring health preventive versus curative measures of (care) status, their progress and success- care, and health competence and literacy. ful activities is vital. Social solidarity and a We understand that health is not only robust connection to civil society is here dependent on e£ective medicine but inevitable. A good level of health literacy essentially on overall health orientation of decision makers and population will in our health care structures with public fuel steady improvement. PROGRAM 37

CHAIR

Bernadette Klapper Robert Bosch Foundation | Senior Vice President Health Division | Germany

Bernadette Kristin Klapper Sørensen 38 SUNDAY, OCTOBER 25

WORKSHOP

WS 04 CHANGES IN HEALTH RESEARCH

SAAL 5 | OCEANIA DURING AND AFTER THE COVID-19 ERA CET: 14:00 – 15:30

HOSTS

Berlin Institute of Health (BIH)

Charité – Universitätsmedizin Berlin

QUEST Center

As an unprecedented global health Other COVID-19 related issues are emergency, COVID-19 has also caused relatively new such as the allocation substantial change in the research pro- of scarce research resources and the cess: health research fighting COVID-19 negative impact on non-COVID-19 is faster, more open, and more collabo- research. The rapid changes of current rative than usual. It has both profited biomedical research thus go beyond the from and further accelerated pre-existing quality and ethics of COVID-19 research practices like preprint publishing and specifically, and lead to questions on data sharing, and has expedited ethics- future developments of research as a review and marketing approval. These whole: What can we learn from these changes elicit wide discussions, and have changes? Will they be lasting? Why been both hailed and criticized. However, should global research on other deadly most controversies regarding openness, diseases such as tuberculosis, malaria, secondary-use of routine health data, cancer, or dementia be less open and translational success, re-purposing, and less collaborative? And how are we regulatory frameworks were apparent to shape these changes to advance the already before the pandemic, providing global health research system? a backdrop to these discussions. PROGRAM 39

The speakers are all at the forefront of ultimate translation of research ﬁndings. changes precipitated by COVID-19 and They will contribute their views on the represent di£erent steps of the research pandemic’s long-term impacts: whether process, from assessment and approval health research will and should change, through conduct and publishing to the and if so, how.

Christopher Ben

Baum Goldacrel PROGRAM, SUN 25 CHAIRS

Theodora Andreas Alois SPEAKERS Bloom Reis

Christopher Baum Ben Goldacre Berlin Institute of Health (BIH) | CEO | University of Oxford | Germany Nu±eld Department of Population Health| Senior Clinical Research Fellow at the Theodora Bloom Centre for Evidence-Based Medicine | The BMJ | Executive Editor | United Kingdom United Kingdom Andreas Alois Reis Ulrich Daniel Dirnagl Strech World Health Organization (WHO) | Senior Ethics O±cer 40 SUNDAY, OCTOBER 25

PANEL DISCUSSION

PD 07 A FAST EUROPEAN RESPONSE Live | SAAL 1 TO PANDEMICS USING DATA AND RUDOLF VIRCHOW Overﬂow | SAAL 6 JOINT INVESTMENTS IN HEALTH EUROPE

16:00 – 17:30 HOST

Sanoﬁ

Europe has spent 2020 dealing with the assess rapidly the e£ectiveness of both COVID-19 pandemic, which has caused social and biomedical interventions. unprecedented health and economic A discussion will start on how these new impact across countries. partnerships might be funded.

It may be too early to analyze and learn Panel 2 will focus on how that funding every lesson from this experience, how- may underpin new joint approaches to ever it is clear that responses to future EU health security and crisis prepared- pandemics will require closer cooperation ness, including rapid deployment of between countries and new models of emergency care capacity and new health public-private partnership to introduce technologies. It also involves develop- innovation in health products, data and ment of ﬂexible, state-of-the art, digital- healthcare systems. ized facilities for production of vaccines and medicines, which would ultimately This session, organized in two panels, support EU competitiveness and resil- will focus on the development of such ience. It will be important to have con- cooperation. tinued evolution of sharing of skills and knowledge between agencies and greater Panel 1 will look at the role data has played regulatory ﬂexibility based upon that in predicting, tracing and containing in - interconnectedness. fections. It will mostly focus on what may be possible in the future if proper privacy The session will maximize participation protections can be assured and if coun- through electronic systems to poll, prior- tries collaborate to use the predictive itize topics and collect the compelling power of big data and new techniques to questions from the audience. PROGRAM 41

CHAIR

Mark Chataway Hyderus | Managing Director | United Kingdom

SPEAKERS Olivier Mark Véran Chataway PROGRAM, SUN 25 Olivier Véran Jürgen Müller Ministry of Social A£airs and Health | SAP SE | Chief Technology O±cer (CTO) Minister of Solidarity and Health | and Member of the Executive Board | France Germany

Andrea Ammon Lothar H. Wieler European Centre for Disease Prevention Robert Koch Institute (RKI) | President | and Control (ECDC) | Director | Germany Andrea Jürgen Sweden Ammon Müller

Olivier Charmeil Sanoﬁ | General Medicines | Executive Vice President | France

Olivier Lothar H. Charmeil Wieler 42 SUNDAY, OCTOBER 25

PANEL DISCUSSION

PD 08 BRINGING THE COVID-19 EPIDEMIC

SAAL 10 | ASIA UNDER CONTROL 16:00 – 17:30 The Need for Research & Innovation

HOSTS

Charité – Universitätsmedizin Berlin

Max Planck Institute for Infection Biology

COVID-19 caused by SARS-CoV-2 has E±cacious treatment by antiviral com- changed the world. It is obvious that it pounds is progressing and emphasis has can only be brought under control by been given to drugs that had been devel- breakthroughs in research & innovation. oped previously for other viral infections. These include, ﬁrst of all, the 3 canonical pillars of medical intervention, namely Global access to e±cacious intervention diagnosis, therapy and vaccination. measures, notably vaccines, will face In addition, host-directed therapies and the issue of (i) supply of large numbers biomarkers are needed. (hundreds of millions) of doses and (ii) a£ordable price. Hence, discussions Diagnosis of SARS-CoV-2 infection based need to be initiated as soon as possible on RNA measurements is well established on issues such as rapid large-scale vac- and broadly used. Diagnosis of immunity cine production and a£ordable pricing to SARS-CoV-2 based on serum antibody (e.g. dual-price concepts for high vs. measurements is in progress and vali- low income countries). dated tests will become available soon. PROGRAM 43

CHAIR

Stefan H.E. Kaufmann Max Planck Institute for Infection Biology | Director Emeritus | Germany

SPEAKERS Ruxandra Depei Draghia-Akli Liu PROGRAM, SUN 25 Ruxandra Draghia-Akli Depei Liu Janssen Pharmaceutical Companies Chinese Academy of Engineering (CAE) | of Johnson & Johnson | Former Vice President, President IAP | Global Public Health | Global R&D Head | China United Kingdom Trevor Mundel Victor J. Dzau Bill & Melinda Gates Foundation |

National Academy of Medicine | President of Global Health | Victor J. Trevor President | United States of America Dzau Mundel United States of America Soumya Swaminathan Richard Hatchett World Health Organization (WHO) | Coalition for Epidemic Preparedness Chief Scientist Innovations (CEPI) | CEO | Norway

Richard Soumya Hatchett Swaminathan

Stefan H.E. Kaufmann 44 SUNDAY, OCTOBER 25

PANEL DISCUSSION

PD 09 STRONG PARTNERSHIPS

SAAL 2 | AMERICA AS A DETERMINANT OF HEALTH 16:00 – 17:30 Bridging the Public, Private, and Political Powers to Accelerate the Attainment of the 2030 SDGs

HOSTS

GHA – German Health Alliance

UNAIDS

UNITE

One thing the sustainable development number of people requiring interventions agenda has projected to the globe is against neglected tropical diseases by the interdependency among the goals. 90%, among others (UNITE, 2019). On the road to reach the 2030 SDGs, it becomes clear that urgent commitments Evidence shows that to progress globally are needed to accelerate the attainment in achieving these goals will demand a of health-related targets and SDG 3 paradigm shift, with new ways of doing (Ensure healthy lives and promote well- partnerships and securing commitments being for all at all ages). With the current at local, national and global levels (Bekker health landscape, where infectious dis- at al., 2019). The SDG 17 (Partnerships for eases account for near 4.3 million deaths the Goals) acknowledges that successful (1.7 million female and 2.7 million male), attainment of the sustainable develop- a common agenda setting between the ment agenda requires e£ective partner- public and private sectors, that is lever- ships to unlock the transformative power aged by political powers and inﬂuences, of trillions of dollars of private resources is the determinant to achieve the 95-95- to deliver on sustainable development 95 HIV/AIDS goals, reduce viral hepatitis objectives (United Nations, 2015). infections to 900,000, reduce malaria case incidence by 90%, reduce mortality Considering this, UNITE–The Global rate by tuberculosis by 90%, reduce the Parliamentarians Network to End Infec- PROGRAM 45

tious Diseases, steps forward to place United Nations Program on HIV/AIDS to the role of partnerships for e£ective promote a discussion and generate key accomplishment of the 2030 SDGs on recommendations on how to strengthen the global health agenda. It does so sustainable partnerships that are backed in partnership with the GHA–German by political will to attain the e£ective

Health Alliance, and the UNAIDS–Joint achievement of health-related SDGs. Hila Hon. Given

Azadzoy Katuta PROGRAM, SUN 25

CHAIR

Ricardo Baptista Leite UNITE | Founder and President | Portugal

SPEAKERS Ricardo Hendrik Hon. Given Katuta Baptista Leite Streeck Hila Azadzoy Inter-Parliamentary Union (IPU) | Ada Health GmbH | Managing Director Advisory Group on Health | Member of of Global Health Initiatives | Parliament and Head of Group | Germany Zambia Winnie Byanyima Hendrik Streeck Joint United Nations Programme on HIV University Bonn | and AIDS (UNAIDS) | Executive Director Institute of Virology and HIV Research | Winnie Andrew Roland Göhde Director of the Institute | Byanyima Ullmann GHA–German Health Alliance | Germany Chairman of the Board | Andrew Ullmann Germany German Bundestag | Member of Parliament | Germany

Roland Göhde 46 SUNDAY, OCTOBER 25

WORKSHOP

WS 05 RECOUPLING SOCIETAL WEALTH

SAAL 4 | AFRICA AND INDIVIDUAL HEALTH 16:00 – 17:30 From Eciency to Resilience

HOST

Global Solutions Initiative

The COVID-19 pandemic was a stark and human wellbeing—(individual) health reminder that health care systems in has thus been decoupled from (societal) many countries lack the resources and wealth in many countries. resilience to cope with unexpected shocks. Beyond the current crisis, there is also Focusing on the G20 as the largest stark di£erences between (wealthy) economies and some of the world´s countries’ capability to provide their wealthiest societies; this panel takes stock citizens with the best health care possi- of the performance of national health ble. One primary reason is the strong systems in the COVID-19 pandemic and focus in recent years and decades on beyond and asks for ways to recouple making national health care more e±- health and wealth as part of a more cient, instead of focusing on resilience human-centered development model. PROGRAM 47

CHAIR

Dennis J. Snower Global Solutions Initiative | President | Germany

SPEAKERS Francesca Dennis J. Colombo Snower PROGRAM, SUN 25 Francesca Colombo Agnés Soucat Organization for Economic Cooperation World Health Organization (WHO) | and Development (OECD) | Director for Health Systems, Head of the Health Division | Governance and Financing France Dana Vorisek Detlev Ganten World Bank | Development Economics

World Health Summit | President | Prospects Group | Senior Economist | Detlev Agnés Germany United States of America Ganten Soucat

Benoît Miribel French Foundation Center (CFF) | Chairman of the French Foundations Center (CFF) and Secretary General of the foundation One Sustainable Health for All |

France Benoît Dana Miribel Vorisek 48 SUNDAY, OCTOBER 25

WORKSHOP

WS 06 TRANSLATION

SAAL 5 | OCEANIA IN THE TIMES OF COVID-19 16:00 – 17:30

HOST

Berlin Institute of Health (BIH)

Translational research is part of a bidirec- towards more personalized therapeutic tional process in which research findings approaches. Information on individuals’ are moved from the researcher’s bench to genomic/transcriptomic profiles, in the patient’s bedside, but also back from combination with lifestyle and environ- clinical findings into mechanistic research. mental factors, are integrated to guide Development of new diagnostic and medical decisions in terms of prevention, informatics methods has seen a trend diagnosis, and treatment of disease. PROGRAM 49

CHAIR

Christof von Kalle Berlin Institute of Health (BIH) | BIH-Chair for Clinical Translational Sciences and Director of the Clinical Study Center | Germany Catharina Jochen Boehme Rupp PROGRAM, SUN 25

SPEAKERS

Catharina Boehme Jochen Rupp Foundation for Innovative Bosch Healthcare Solutions | New Diagnostics (FIND) | CEO | Head of Product Management Vivalytic | Switzerland Germany Patrice Peter H. Patrice Debré Peter H. Seeberger Debré Seeberger Académie Nationale de Médecine | Max Planck Institute of Colloids President of the International and Interfaces | Director | Relations Committee | Germany France

Ralf Heyder Charité–Universitätsmedizin Berlin |

Head of Administrative O±ce Ralf Christof for External Networking and Heyder von Kalle Strategic Partnerships | Germany 50 SUNDAY, OCTOBER 25

KEYNOTE

KEY 01 OPENING CEREMONY SAAL 1 RUDOLF VIRCHOW 18:00 – 19:30

HOSTS

M8 Alliance

World Health Summit PROGRAM 51

CHAIRS

SPEAKERS

Frank-Walter Steinmeier Paul Hudson Federal President | Sanoﬁ | CEO | Germany France

Ursula von der Leyen Winnie Byanyima Ursula Paul Detlev European Commission | Joint United Nations Programme von der Leyen Hudson Ganten President on HIV and AIDS (UNAIDS) | Executive Director António Guterres United Nations | Nanette Cocero Secretary-General Pﬁzer Inc. | Global President of Pﬁzer Vaccines | Tedros Adhanom Ghebreyesus United States of America World Health Organization (WHO) | Director-General António Winnie Charles Guterres Byanyima Ibingira 52 53

PROGRAM

MONDAY, OCTOBER 26 54 MONDAY, OCTOBER 26

KEYNOTE

KEY 02 ACHIEVING HEALTH FOR ALL SAAL 1 THROUGH DIGITAL COLLABORATION RUDOLF VIRCHOW 9:00 – 10:30

HOST

World Health Organization (WHO)

Digital technologies are revolutionizing The purpose of this event is to engage healthcare and provide unprecedented the multi-stakeholder digital community opportunities to improve health and to contribute to the prioritization, adop- wellbeing worldwide, transform econo- tion and acceleration of digital health mies, and stimulate growth. For the first technologies and create a strong and time in history, we have new tools to sustainable partnership model for digital solve health system problems and create health as we encourage key stakeholders an equitable global health future. to invest in the global digital health ecosystem. If we are to realize the benefits of digi tal transformation in health care, it will take Please find the draft agenda here: a global collaboration among Govern- https://www.who.int/docs/default- ments, Development Partners and Donors, source/digital-health-documents/whs- the Private Sector, Civil Societies, Acade- who-event-draft-agenda.pdf mics, and NGOs. PROGRAM 55

MODERATOR

Amandeep Singh Gill Project Director, International Digital Health & AI Research Collaborative (I-DAIR) | Switzerland

Tedros Adhanom Bernardo Ghebreyesus Mariano Jr. SPEAKERS

Tedros Adhanom Ghebreyesus Bernardo Mariano Jr. World Health Organization (WHO) | World Health Organization (WHO) | Director-General Department of Digital Health and Innovation | Director of the Department Stella Kyriakides and the Chief Information O±cer European Commission | Commissioner for Health and Food Safety | Aishath Samiya Stella Rajiv

Belgium Permanent Secretary | Ministry of Health | Kyriakides Shah PROGRAM, MON 26 Maldives Soumya Swaminathan World Health Organization (WHO) | Rajiv Shah Chief Scientist Rockefeller Foundation | President | United States of America Dame Sally Davies UK Government | Department of Miriam K. Were Health and Social Care | Special Envoy The Champions for an AIDS-Free on Antimicrobial Resistance | Generation in Africa | Deputy Chair | Soumya Miriam K. Swaminathan Were United Kingdom Botswana

Dame Sally Davies 56 MONDAY, OCTOBER 26

PANEL DISCUSSION

PD 10 NATIONAL RESPONSES

SAAL 6 | EUROPE TO COVID-19 9:00 – 10:30

HOSTS

M8 Alliance

Tehran University of Medical Sciences (TUMS)

The George Washington University, Milken Institute School of Public Health Tehran University of Medical Sciences COVID-19 has a£ected all parts of the and impact. To some this diversity of world as a global pandemic, a£ecting responses is surprising given the common more people than recent epidemics. Yet experience of COVID-19; while to others nation states have responded di£erently, this is a sign of variations in the political at variable time frames and with a diver- and contextual factors that a£ect deci- sity of political and public health actions. sion making. Tehran University of Medical Sciences (TUMS) is accredited with premier status by the Accreditation Service for International Colleges (ASIC). ASIC is recognized by the United Kingdom Department for Education and Skills (DfES), the United Kingdom Department for Universities, Innovation and Skills (DUIS), the United Kingdom Border and Immigration Agency (Home Office), the United Kingdom Office for Standards in Education (Ofsted). ASIC is a member of Council for Higher Education Accreditation (CHEA).Scientists, experts, health professionals and researchers have been a part of these This session will discuss experiences from responses, and have also studied these several parts of the world around the action to try and define their motivations following key questions below. PROGRAM 57

CHAIRS

Adnan A. Hyder Amirhossein Takian The George Washington University | Tehran University of Medical Sciences Milken Institute School of Public Health | (TUMS) | Department of Senior Associate Dean for Research Global Health & Public Policy | and Professor of Global Health | Chair of Department and Vice Dean | Chang-Chuan Adnan A. Chan Hyder United States of America Iran

SPEAKERS

Chang-Chuan Chan Martin Fitchet National Taiwan University | Johnson & Johnson | Associate Dean | Head of Global Public Health | Taiwan United States of America Margaret Joanna

Chan Nurse PROGRAM, MON 26 Margaret Chan Joanna Nurse Boao Forum For Asia | President InterAction Council | Strategic Advisor | United Kingdom

Martin Amirhossein Fitchet Takian 58 MONDAY, OCTOBER 26

PANEL DISCUSSION

PD 11 CLIMATE CHANGE AND HEALTH Risks and Responses SAAL 10 | ASIA 9:00 – 10:30

HOSTS

London School of Hygiene & Tropical Medicine (LSHTM)

M8 Alliance

Our increasing understanding of climate depend on supplies of food and water, change is transforming how we view the low exposure to major infectious diseas- boundaries and determinants of human es, and a stable climate. Unprecedented health. While our personal health may changes are occurring in natural systems seem to relate mostly to prudent behav- that threaten to undermine progress in ior, heredity, occupation, local environ- human health. Urgent action is needed mental exposures, and health-care access, to reduce the greenhouse gas emissions sustained population health requires the leading to rapid climate change and to life-supporting “services” of natural sys- address other environmental trends that tems. Populations of all animal species pose increasing risks to human health. PROGRAM 59

CHAIR

Sabine Gabrysch Sir Andrew Haines Charité–Universitätsmedizin Berlin | London School of Hygiene and Tropical Professor for Climate Change and Health | Medicine (LSHTM) | Professor of Environ- Germany mental Change and Public Health | United Kingdom Niels Rachel Annen Huxley

SPEAKERS

Niels Annen Jeni Miller Federal Foreign O±ce | The Global Climate and Health Alliance | Minister of State| Executive Director | Germany United States of America Sabine Jeni

Andrew Carlos A. Haines Nobre 60 MONDAY, OCTOBER 26

PANEL DISCUSSION

PD 12 ACCESS TO SUSTAINABLE

SAAL 2 | AMERICA NCD TREATMENT & CARE 9:00 – 10:30

HOSTS

Boehringer Ingelheim Pharma GmbH & Co. KG

The Defeat-NCD Partnership

More than half of all countries will fail experts and leaders from Governments, to meet SDG target 3.4 by 2030. By all United Nations, World Health Organiza- measures, the reduction by one-third tion, African Union, Association of South- of premature mortality due to non-com- east Asian Nations, regional development municable diseases (NCDs), can and banks, and the private sector to reflect should be achieved through prevention on how progress can be made towards and treatment. this ambitious goal, o£ering di£erent perspectives not just on the importance The political will and leadership is there, of a robust action plan, but on what it and in many cases a coherent NCD takes to implement such ambitious plans. strategy is in place. But although their role is vital, these strategies need to be In light of this, the discussion will focus on translated into costed action plans that tangible ways in which leadership, politi- bring together public and private actors cal will, and strong partnerships between to work alongside governments. Every the public and private sector actors can part of society must take responsibility improve patient care (in particular reflect- to bridge the trillion-dollar funding gap ing the importance of partnerships in and find creative ways to bring about helping NCD patients during emergencies better health outcomes for NCDs. like COVID-19), strengthen health systems, and create access to financing through This panel discussion will bring ministers cost reduction and unlocking new fund- at the forefront of tackling NCDs in ing streams. Rwanda and Myanmar together with PROGRAM 61

MODERATOR

Juliette Foster Magnus Communications | Founder and Managing Director | United Kingdom

SPEAKERS Mukul H.E. Myint Bhola Htwe Bente Mikkelsen H.E. Myint Htwe World Health Organization (WHO) | Ministry of Health and Sports | Division of Noncommunicable Diseases Minister of Health and Sports | and Promoting Health through the Myanmar Life-course | Director H.E. Daniel Ngamije H.E. Amira Elfadil Mohammed Elfadil Ministry of Health |

African Union Commission | Minister of Health | H.E. Amira Elfadil Bente

Commissioner for Social A£airs | Rwanda Mohammed Elfadil Mikkelsen PROGRAM, MON 26 Ethiopia Mukul Bhola Hubertus von Baumbach The Defeat-NCD Partnership | CEO | Boehringer Ingelheim Pharma GmbH Switzerland & Co. KG | Chairman of the Board of Managing Directors | Germany

Juliette H.E. Daniel Foster Ngamije 62 MONDAY, OCTOBER 26

WORKSHOP

WS 07 MULTI STAKEHOLDER COLLABORATION

SAAL 4 | AFRICA IN GLOBAL HEALTH RESEARCH 9:00 – 10:30 Science Meets Implementation

HOST

German Federal Ministry of Education and Research (BMBF)

The session will explore the relationships (e.g. di£erent Ministries and Depart- and intersections of development coop- ments) and improve the coherence, eration and academic research in global e±ciency and capacity for action of health. How can political, ﬁnancial and donor countries? What kind of programs human resources investments in huma- and incentives are needed to ensure nitarian development cooperation be that development cooperation programs sensibly linked to academic research? are evidence based and that academic What kind of coordination mechanisms cooperation’s have a positive impact are needed to overcome fragmenta - on social and economic development tion between or even within sectors in the partner countries? PROGRAM 63

CHAIRS

Walter Bruchhausen Johanna Hanefeld University Hospital Bonn | London School of Hygiene Section Lead Global Health, and Tropical Medicine (LSHTM) | Social and Cultural Aspects | Lead LSHTM Berlin and Associate Professor | Professor Health Policy and Systems | Walter Achim Bruchhausen Hörauf Germany Germany

SPEAKERS

Achim Hörauf Caroline Schmutte University Hospital Bonn | Wellcome Trust | Institute of Medical Microbiology, Germany O±ce Lead | Immunology and Parasitology | Germany Johanna Caroline

Hanefeld Schmutte PROGRAM, MON 26 Director of the Institute | Germany

Birgit Pickel Federal Ministry for Economic Cooperation and Development (BMZ) | Global Health, Pandemic Prevention, One Health | Director | Germany 64 MONDAY, OCTOBER 26

WORKSHOP

WS 08 PANDEMICS AND OPERATIONALIZING

SAAL 5 | OCEANIA ONE HEALTH 9:00 – 10:30 Working within the Framework of the Global Action Plan for SDG 3

HOSTS

German Federal Ministry for Economic Cooperation and Development (BMZ)

The Lancet One Health Commission

In 2018 Germany, Norway and Ghana diseases. Domestic livestock can then initiated the Global Action Plan (GAP) for serve as amplifying hosts for recent SDG 3, signed by 12 mainly UN Organi- pathogen spillover events. Viruses can zations. However the globally disruptive also mix in di£erent domestic animal nature of infectious disease pandemics compartments and interact with human of zoonotic origin (COVID-19, Ebola and viruses to produce highly pathogenic swine flu being recent examples), evi- human viruses (i.e. Influenza viruses). denced by their profound direct impact The frequency, intensity and impact of on global health, and compounded by these pandemics and their e£ect on economic and social e£ects, are a major global health is closely interlinked with threat to achieving SDG 3. several factors, including global trade and mobility, climate change, antimicrobial While recently emerging infectious di - resistance and an increase in the burden seases have come about through viruses of non-communicable diseases. jumping from wild animals to humans, pandemics can be fundamentally blamed For the GAP to be successful in helping on changes to relationships between to achieve SDG 3, it requires coordinated humans and animals and to their shared and e±cient action across multiple environment Domestic animals can be disciplines and sectors which takes into the source of zoonotic diseases such as account the risk of pandemics and how tuberculosis or brucellosis but in addition quickly they can roll back any progress livestock and wild animals may also act made. In addition to defined commit- as bridges for the emergence of human ments and proposed actions in the GAP PROGRAM 65

to improve inter-institutional cooperation shift that the GAP demands and accel- and thus the situation of countries imple- erate progress towards SDG 3. At this menting SDG 3, One Health provides a year’s World Health Summit, The Lancet platform for harnessing the complexity One Health Commission will further of the human-animal-environment inter- explore how to operationalize One Health face in which these global health threats in a sustainable way to address pan de- Maria Camilla are implicated for achieving the SDGs. mics and ultimately SDG 3 through the Flachsbarth Stoltenberg GAP—involving the community/grass- In two sessions at the World Health roots, health professionals, scientists, Summit 2019, The Lancet One Health researchers and academia across disci- Commission undertook a Health consen- plines, the next generation of students sus-seeking mission on the concept of and young professionals, and at the One Health, and examined the potential political level. of One Health to catalyze the paradigm

John Lothar H.

Amuasi Wieler PROGRAM, MON 26 CHAIRS

John Amuasi Andrea Winkler Lancet Commission on One Health | Lancet Commission on One Health | Co-Chair | Ghana Co-Chair | Germany

SPEAKERS Jean Scheftsik Andrea de Szolnok Winkler Maria Flachsbarth Anthony Nsiah-Asare Federal Ministry for Economic O±ce of the President | Cooperation and Development (BMZ) | Presidential Advisor on Health | Parliamentary State Secretary | Ghana Germany Camilla Stoltenberg Jean Scheftsik de Szolnok Norwegian Institute of Public Health | Boehringer Ingelheim Pharma GmbH Director-General | Norway & Co.KG | Member of the Board of Anthony Lothar H. Wieler Nsiah-Asare Managing Directors and Head of the Robert Koch Institute (RKI) | President | Animal Health Business Unit | Germany Germany 66 MONDAY, OCTOBER 26

KEYNOTE

KEY 03 STRENGTHENING THE SAAL 1 ROLE OF THE EUROPEAN UNION RUDOLF VIRCHOW 11:00 – 12:30 IN GLOBAL HEALTH

HOSTS

German Federal Ministry of Health (BMG)

Germany’s Presidency of the Council of the European Union

In recent years, Germany has strength- a priority during its 2020 EU presidency, ened its commitment to global health, in cooperation with its trio-partners leveraging its G7 and G20 presidencies Portugal and Slovenia. This presents a and lending support to multilateral and signiﬁcant opportunity to help identify bilateral health partnerships. It has also interventions in areas like development, become one of the strongest supporters health, research, environment, and trade of the World Health Organization and that all EU members can implement to other international agencies. Germany achieve SDG 3. has announced that global health will be PROGRAM 67

CHAIR

Ilona Kickbusch The Graduate Institute of International and Development Studies | Global Health Center | Chair of the International Advisory Board | Switzerland Jens Bernhard Spahn Schwartländer

SPEAKERS

Jens Spahn Tomaž Gantar Federal Ministry of Health (BMG) | Ministry of Health | Federal Minister of Health | Minister of Health | Germany Slovenia

Marta Temido Bernhard Schwartländer Marta Ilona

Ministry of Health | World Health Organization (WHO) | Temido Kickbusch PROGRAM, MON 26 Minister of Health | Chief of Sta£ Portugal

Tomaž Gantar 68 MONDAY, OCTOBER 26

PANEL DISCUSSION

PD 13 SETTING A NEW AGENDA

SAAL 6 | EUROPE FOR WOMEN AND CANCER 11:00 – 12:30

HOST

Roche

Women are the cornerstone of all socie- to recognize and act upon the impor- ties—in families, healthcare, communities tance of the role of women. and the workplace. They not only face unique challenges in maternal and re - Now, with the unprecedented disruption productive health, but even in diseases brought by COVID-19, how can we look not unique to women, they often have to the future to support an agenda and poorer outcomes. Perhaps most critically, initiatives that positively support women’s NCDs have been the leading cause of health moving forward? women’s mortality for decades. In cancer, for example, in addition to the 8.5 million In this session Roche will bring together newly diagnosed cases a year, the lion’s experts from the public and private share of family and community care falls sectors to assess the current status of on women the world over. The women’s women’s health, particularly in regard perspective has not been central to policy to cancer. decision making and we have been slow PROGRAM 69

CHAIR

Shiulie Ghosh Aero Productions | International Journalist, TV Presenter, Writer and Moderator | United Kingdom

Cecilia Teresa Bonefeld-Dahl Graham SPEAKERS

Shiulie Isabel Ghosh Mestres 70 MONDAY, OCTOBER 26

WORKSHOP

WS 09 EVIDENCE-BASED DECISION-MAKING

SAAL 4 | AFRICA IN GLOBAL HEALTH 11:00 – 12:30 What is Evidence and How is it Used in Making Decisions about COVID-19

HOSTS

German Alliance for Global Health Research

German Federal Ministry of Education and Research (BMBF)

COVID-19 has sparked a lively societal di£erent stages of the pandemic as well discourse about the relationship between as the di£erent types of evidence that science and policy in numerous countries researchers provide and politicians a£ected and on a global level. The session and authorities base their decision on examines the role and contributions of (e.g. individual publications and reviews). di£erent research disciplines (virology, It furthermore sheds light on di£erent intensive care medicine, epidemiology, models of research- policy relationships sociology, economy, ethics, etc.) at and mutual inﬂuence. PROGRAM 71

CHAIRS

Eva Rehfuess Maike Voss Ludwig-Maximilians-Universität München German Institute for International (LMU Munich) | Chair of Public Health and Security A£airs (SWP) | and Health Services Research | Scientist | Germany Germany Yvonne Fernando Doyle Simón

SPEAKERS

Yvonne Doyle Fernando Simón Public Health England | Medical Director Ministry of Health | and Director for Health Protection | Coordination Centre for Health Alerts United Kingdom and Emergencies | Director | Spain Christian Soumya Christian Drosten Drosten Swaminathan PROGRAM, MON 26 Charité–Universitätsmedizin Berlin | Soumya Swaminathan Institute of Virology Campus Charité World Health Organization (WHO) | Mitte | Director of the Institute | Chief Scientist Germany

Frode Forland Norwegian Institute of Public Health |

Infectious Diseases and Global Health | Frode Maike Specialist Director | Forland Voss Norway

Eva Rehfuess 72 MONDAY, OCTOBER 26

WORKSHOP

WS 10 INFECTCONTROL—INVESTING IN THE

SAAL 5 | OCEANIA ONE HEALTH APPROACH 11:00 – 12:30 A Federally Funded Initiative that Overcomes Barriers between Sectors and Disciplines to Prevent, Quickly Diagnose, and Eectively Fight Infectious Diseases

HOSTS

German Federal Ministry of Education and Research (BMBF)

InfectControl

Why is it necessary that medical doctors hospitals. For a better and faster diagno - and infection biologists join forces with sis of infectious diseases the consortium veterinarians, architects, climate-, mate- is developing new rapid tests for specific rial- and communication scientists to pathogens and new analysis methods. fight infections? InfectControl also promotes the devel- The workshop gives an overview about opment of vaccines and drugs. In colla - the German-wide, BMBF-funded research bo ration with the German Center for program InfectControl and introduces Infectious Research (DZIF), InfectControl some of its flagship projects. It is a unique currently develops a new tuberculosis collaboration in Germany involving experts drug (clinical phase IIa) that has a com- from a wide range of disciplines and spe - pletely new mode of action and is also cialist areas. Together, they fight infections e£ective against resistant strains. that a£ect Germany and Europe in par- In the workshop, members of the con- ticular following the One Health approach sortium will present prominent results with the aim to sustainably prevent infec- from their interdisciplinary projects. tious diseases, to detect them faster and Following the presentations the Infect- to fight them comprehensively. Control consortium will discuss with To prevent infectious diseases, InfectCon- the audience the hurdles and future trol supports educational campaigns as per s pectives for One Health initiatives well as the development of new techniques that are necessary to fight infectious and standards, e.g. for patient rooms in diseases. PROGRAM 73

CHAIR

Axel Brakhage Leibniz Institute for Natural Product Research and Infection Biology– Hans Knöll Institute (Leibniz-HKI) | Director | Germany Axel Peter Brakhage Schmid

SPEAKERS

Oliver Kurzai Wolfgang Sunder Gastmeier Sunder PROGRAM, MON 26 Leibniz Institute for Natural Product Technical University of Braunschweig | Research and Infection Biology– Institute for Industrial Construction Hans Knöll Institute (Leibniz-HKI) | and Structural Design | Professor and Chair | Head of Research | Germany Germany

Thomas C. Mettenleiter Lothar H. Wieler Friedrich Loe¾er Institute (FLI) | Robert Koch Institute (RKI) | Oliver Lothar H. President | President | Kurzai Wieler Germany Germany

Thomas C. Mettenleiter 74 MONDAY, OCTOBER 26

PANEL DISCUSSION

PD 14 CLIMATE CHANGE

SAAL 10 | ASIA AND HEALTH 12:30 – 14:00 IAP Project Regional Assessment

HOSTS

Association of Academies and Societies of Sciences in Asia (AASSA)

Inter-American Network of Academies of Science (IANAS)

InterAcademy Partnership (IAP)

The Network of African Science Academies (NASAC)

There are many pathways, direct and and the Americas (IANAS), building on indirect, mediating the e£ects of climate previous work done in Europe (EASAC). change on human health. There is sig- The regional outputs will all be published niﬁcant variation within and between by early 2021, to be followed by a global regions and amongst di£erent population synthesis report to explore regional groups. While there is also increasing similarities and di£erences, inter-regional political awareness of the issues and issues and global priorities. a rapidly accumulating evidence base, there has been less focus on solutions: The session invites regional perspectives how to develop resilience, adaptation (virtual) from academy network experts in health systems and health co-beneﬁts on emerging issues and on key points of climate change mitigation. that require further exploration. Discus- sion with the audience worldwide will be The IAP project (https://www.interacad- encouraged to help ensure that a wide emies.net/project/climate-change-and- range of inputs is captured by the pro - health), aiming to inform policy-makers ject, also providing national, regional and and other stakeholders, is progressing in global perspectives in preparation for parallel with the regional academy net- COP 26. works in Africa (NASAC), Asia (AASSA) PROGRAM 75

CHAIR

Volker ter Meulen Julius Maximilians University of Wuerzburg | President of IAP and Co-Chair of IAP Project | Germany Khairul Jeremy Abdullah McNeill

SPEAKERS

Khairul Abdullah Jeremy McNeill MAHSA University | University of Western Ontario | AASSA Working Group Chair | IANAS Working Group Chair | Malaysia Canada

Robin Fears Volker ter Meulen Robin Volker

InterAcademy Partnership (IAP) | Julius Maximilians University Fears ter Meulen PROGRAM, MON 26 Project Coordinator | of Wuerzburg | President of IAP Italy and Co-Chair of IAP Project | Germany Sir Andrew Haines London School of Hygiene and Caradee Wright Tropical Medicine (LSHTM) | South African Medical Research IAP Project Co-Chair | Council (SAMRC) |

United Kingdom NASAC Working Group Chair | Sir Andrew Caradee South Africa Haines Wright 76 MONDAY, OCTOBER 26

PANEL DISCUSSION

PD 15 YOUTH PERSPECTIVES

SAAL 2 | AMERICA ON HEALTH 12:30 – 14:00 COVID-19 and Gender Engagement

HOST

International Federation of Medical Students’ Associations (IFMSA)

Today, youth constitute more than 1.8 pandemic as well as best practices on billion people living on earth, represent- youth taking the lead on COVID-19 re- ing one-third of the population and a sponse not only in healthcare but also high percentage of the health workforce. in the communities.

The session will bring together young In the second part of the event, the and senior stakeholders from academia, speakers will share their reﬂections on international development, government, the most urgent questions in the face NGOs and private sector, who work on of pandemic, including the gender lens initiatives tackling the uncertainty of and exacerbation of inequalities revealed. COVID-19 crisis. It will have two parts: Moreover, the event will allow young people to network and participate in the First an interactive panel will serve as “meet-and-greet” session as the o±cial both a space to share the challenges closing of the session. youth face amidst the unprecedented PROGRAM 77

CHAIR

Eglė Janušonytė International Federation of Medical Students’ Associations (IFMSA) | Vice President for External A£airs 2020/2021 | Denmark Ieva Omnia Caline Berankytė El Omrani Mattar

SPEAKERS

Hera Ali Omnia El Omrani International Pharmaceutical International Federation of Students’ Federation | Medical Students’ Associations Chairperson of Public Health | (IFMSA) | Liaison O±cer for United Kingdom Public Health Issues | Denmark Martin Shymaa Tugce Ieva Berankytė Blohmer Enany Schmitt PROGRAM, MON 26 International Federation of Shymaa Enany Medical Students’ Associations Suez Canal University | (IFMSA) | Liaison O±cer for Department of Microbiology Sexual and Reproductive Health and Immunology | and Rights Issues | Associate Professor | Egypt Denmark Caline Mattar Martin Blohmer Global Health Workforce Nicole Eglė Zsóﬁa Young Leaders for Health | Youth Hub | Chair | De Paula Janušonytė Szlamka Representative | United States of America Germany Tugce Schmitt Nicole De Paula Global Health Next Generation Women Leaders for Planetary Network | Representative | Health–IASS Potsdam | Belgium Executive Director and Founder| Zsóﬁa Szlamka Germany Global Shapers Community | Global Shapers Cambridge | Curator and Co-founder of VOICES | United Kingdom 78 MONDAY, OCTOBER 26

KEYNOTE

KEY 04 PANDEMIC PREPAREDNESS SAAL 1 IN THE AGE OF COVID-19 RUDOLF VIRCHOW Global Cooperation not Competition 14:00 – 15:30

HOSTS

Charité – Universitätsmedizin Berlin

Foundation for Innovative New Diagnostics (FIND)

London School of Hygiene & Tropical Medicine (LSHTM)

M8 Alliance

COVID-19 has called our global pan - safe. New forms of collaboration and de mic preparedness into question. strengthened partnerships have emerged But building on experience with other as central to the response. From science coronaviruses, including SARS and MERS, and research to policy and implemen- and learning lessons from combatting tation, the world has shifted in terms of outbreak diseases including Ebola, pro- our ability to react. How can we build gress is being made with unprecedented back better after COVID-19, and ensure speed to develop the tests, treatments pre paredness for the future? and vaccines needed to keep the world PROGRAM 79

CHAIR

Catharina Boehme Foundation for Innovative New Diagnostics (FIND) | CEO | Switzerland

SPEAKERS Catharina Tom Boehme Frieden Thomas Cueni Jayasree K. Iyer International Federation of Pharma- Access to Medicine Foundation | ceutical Manufacturers & Associations Executive Director | (IFPMA) | Director-General | The Netherlands Switzerland Peter Piot Christian Drosten London School of Hygiene

Charité–Universitätsmedizin Berlin | and Tropical Medicine (LSHTM) | Thomas Jayasree K.

Institute of Virology Campus Charité Director and Professor of Global Health | Cueni Iyer PROGRAM, MON 26 Mitte | Director of the Institute | United Kingdom Germany

Tom Frieden Resolve to Save Lives | President and CEO | United States of America

Christian Peter Drosten Piot 80 MONDAY, OCTOBER 26

PANEL DISCUSSION

PD 16 RADIATION THERAPY AS AN ESSENTIAL

SAAL 6 | EUROPE COMPONENT OF CANCER CONTROL 14:00 – 15:30 Understanding how Innovations are Driving Uptake and Impact in Low- and Middle-Income Countries (LMICs)

HOSTS

International Atomic Energy Agency (IAEA)

Varian Medical Systems

The 43.8 million persons living with for women in LMICs countries who su£er cancer who were diagnosed within the over 90% of all global deaths due to last 5 years demonstrate that cancer is cervical and 70% due to breast cancer a substantial global social and economic (Globocan 2018). burden. in all countries, regardless of development. The International Agency Mobile technology, artificial intelligence for Research on Cancer (IARC) projects (AI) and other emerging technologies are that (by 2030), over 24 million people rapidly changing the delivery of health- will be diagnosed with cancer worldwide care worldwide. This panel discussion will and 13 million will die from the disease share experiences of implementing essen- every year. The rising cancer burden hits tial radiotherapy services and explore low and middle income countries (LMICs) how innovative healthcare solutions in the hardest, many of which are ill-equipped this domain are contributing to increasing to deal with the present situation, reflect- access to safe, e£ective, a£ordable and ed in disparities in cancer survival and sustainable treatment services for cancer survivorship. The extent of implementa- patients in LMICs. Successful strategic tion of national cancer control plans has partnerships between Governments, increased in recent years, allowing access international institutions and the private to health technologies such as radiother- sector will be showcased and represen- apy for quality and cost-e£ective treat- tatives from the IAEA, Varian, Ministries ment for millions of cancer patients for of Health and clinical experts will describe the first time. This is particularly pertinent how new technologies can further close PROGRAM 81

the access gap and improve outcomes 2030 and the newly adopted WHO for patients as well as address the chal- Global Strategy towards elimination lenge of shortage of medical cancer care of cervical cancer as a public health professionals, in support of the Agenda problem.

Supriya Julie CHAIR Chopra Torode

Julie Torode Union for International Cancer Control (UICC) | Deputy CEO and Director of Advocacy and Networks | Switzerland

SPEAKERS Rafael Mariano Dow R.

Grossi Wilson PROGRAM, MON 26 Supriya Chopra Bello Abubakar Mohammed Tata Memorial Centre | Consultant Clinical Oncologist | Associate Professor Radiation Oncology| National Hospital | India Nigeria

Rafael Mariano Grossi Dow R. Wilson International Atomic Energy Agency Varian Medical Systems | (IAEA) | Director-General President and CEO | United States of America 82 MONDAY, OCTOBER 26

WORKSHOP

WS 11 NTDS AND CHALLENGES OF

SAAL 4 | AFRICA THE COVID-19 CRISIS 14:00 – 15:30 How Neglected Tropical Diseases can Contribute to Overcoming Impact and Risks from COVID-19

HOSTS

Association of Research-based Pharmaceutical Companies (vfa)

Eberhard Karls University Tuebingen

German Network against Neglected Tropical Diseases (DNTDs)

German Society for Tropical Medicine and International Health (DTG)

University Hospital Tuebingen

The COVID-19 pandemic has a£ected the likelihood that the burden of NTDs will progress towards elimination of Neglected increase again and many years of e£orts Tropical Diseases (NTDs) in a dramatic will be lost, is high.The NTD-community way: Following the initial recommenda- has to adapt programs and guidelines tions of WHO, the implementation of facing the challenges of the COVID-19 NTD-programs had been suspended but pandemic and continue the pathway a di£erentiated decision-making frame- to elimination of NTDs at the same time. work for recommencing mass treatment Since NTD-programs are providing unique and other NTD interventions is now in platforms that are reaching out to all place. This means that annual mass drug communities in their target areas, assur- administration cycles were interrupted, ing prevention and treatment including no monitoring and evaluation was done, to those who often don’t have access and little to no operational research to health care can also beneﬁt the ﬁght im ple mented. If COVID-19 disrupts NTD- against COVID-19. interventions for a longer period, the PROGRAM 83

CHAIRS

Achim Hörauf Carsten Köhler University Hospital Bonn | University Hospital Tuebingen | Institute of Medical Microbiology, Center of Competence at Institute for Immunology and Parasitology | Tropical Medicine, Travel Medicine Director of the Institute | and Human Parasitology | Irene Carsten Ayakaka Köhler Germany Director of Center of Competence | Germany

SPEAKERS

Irene Ayakaka Johannes Waltz Makerere University College of Health Merck | Global Schistosomiasis Sciences | Uganda Tuberculosis Alliance (GSA) | Head of Merck Constanze Mwelecele Ntuli

Bönig Malecela PROGRAM, MON 26 Implementation Research Consortium Schistosomiasis Elimination Program | (U-TIRC) | Project Manager | Germany Uganda Makoy Yibi Logora Constanze Bönig CBM South Sudan | Vétérinaires Sans Frontières Germany | National NTD Coordinator | Desk O±cer HQ for Humanitarian Aid & South Sudan Development Cooperation | Germany Achim Johannes Hörauf Waltz Mwelecele Ntuli Malecela World Health Organization (WHO) | WHO Regional O±ce for Africa | Director of Department of Control of Neglected Tropical Diseases | Congo 84 MONDAY, OCTOBER 26

WORKSHOP

WS 12 VACCINATION AND

SAAL 5 | OCEANIA TRANSMISSION CONTROL 14:00 – 15:30 What’s New and What Works in Preventing Infections

HOSTS

Leibniz Association

Research Center Borstel – Leibniz Lung Center

Vaccination against and control of vector- menting vector control measures borne transmission of infectious agents (dengue, malaria). The goal is to distill, are prime staples of infection control. from these diverse experiences, a con- The speakers in this session will present sensus on what works best and what their exemplary experience with the doesn’t work in infection control, and development of novel vaccines (tuber- to discuss best practice examples for culosis, ebola), the acceptance of vacci- overcoming obstacles identiﬁed by the nation in the population, or with imple- speakers. PROGRAM 85

CHAIR

Stefan Ehlers Research Center Borstel–Leibniz Lung Center | CEO | Germany

SPEAKERS Marylyn Stefan H.E. Addo Kaufmann Marylyn Addo Stefan H.E. Kaufmann Medical Center Hamburg-Eppendorf | Max Planck Institute for Infection Biology| Head of Division of Infectious Diseases | Director Emeritus | Germany Germany

John Amuasi Steven Sinkins Lancet Commission on One Health | University of Glasgow |

Co-Chair | Centre for Virus Research | Professor John Steven

Ghana in Microbiology and Tropical Medicine | Amuasi Sinkins PROGRAM, MON 26 United Kingdom

Stefan Ehlers 86 MONDAY, OCTOBER 26

PANEL DISCUSSION

PD 17 PERSPECTIVES FROM Live | SAAL 1 THE COVID-19 PANDEMIC RUDOLF VIRCHOW The Importance of Innovation in Maintaining Global Health Security Overﬂow | SAAL 6 EUROPE

16:00 – 17:30 HOST

International Federation of Pharmaceutical Manufacturers & Associations (IFPMA)

Despite the huge societal costs of Anti- Stepping up to the challenge of AMR, microbial Resistance (AMR), there is no the Fund will invest in smaller biotech viable market for new antibiotics. As a companies focused on developing novel result, important antibiotics in the early antibiotics that address the highest stages of development may never reach priority public health needs, make a patients due to a lack of funding for the significant di£erence in clinical practice, later stages of clinical research. To bridge and save lives. While the Fund seeks to this funding gap, over 20 leading phar- make significant tangible progress in the maceutical companies recently launched fight against AMR, it alone will not be a ground-breaking partnership to invest su±cient to solve the challenge, and nearly $1 billion through a new AMR broader policy reforms will be necessary Action Fund that aims to bring 2 to 4 to create an environment that encourages new antibiotics to patients by the end long-term investment into antibiotic of the decade. R&D and rewards innovation.

Both COVID-19 and AMR are signiﬁcant This session will explore the new bio- global health threats that necessitate pharmaceutical industry initiative, the action by all stakeholders in order to be importance of innovation to maintain tackled successfully. Yet there are di£er- global health security as also evidenced ences—unlike COVID-19, AMR is a pre- by COVID-19, as well as foster discussion dictable and preventable threat that is on what is needed for a sustainable not new. Continuous innovation in time, antibiotic innovation ecosystem. and in preparation of, a global pandemic to address current and future global health crises is therefore essential. PROGRAM 87

CHAIR

Astrid Frohlo Journalist | Germany

SPEAKERS Francesca Tim Colombo Jinks Francesca Colombo Stefan Oelrich Organization for Economic Cooperation Bayer AG | and Development (OECD) | Member of the Board of Management Head of the Health Division | President Pharmaceuticals | France Germany

Thomas Cueni Lord Bethell of Romford International Federation of Pharma- Parliament of the United Kingdom | Thomas Stefan ceutical Manufacturers & Associations Parliamentary Under Secretary of State | Cueni Oelrich PROGRAM, MON 26 (IFPMA) | Director-General | Minister for Innovation | Switzerland United Kingdom

Tim Jinks Wellcome Trust | Head of Drug Resistant Infections Priority Program | United Kingdom

Astrid Lord Frohlo£ Bethell of Romford 88 MONDAY, OCTOBER 26

PANEL DISCUSSION

PD 18 CLIMATE CHANGE AND ONE HEALTH Critical Action for a Sustainable Planet SAAL 10 | ASIA 16:00 – 17:30

HOSTS

German National Academy of Sciences Leopoldina

InterAcademy Partnership (IAP)

The Lancet One Health Commission

Now more than ever before, the world ronment has been shown to have direct has been awakened to the threat posed impact on climate, which in turn impacts by diseases which are closely linked to negatively and directly on the shared human-animal-environment interaction, environment, animals and humans. This and which have far-reaching global health complex negative cycle links Climate and socio-economic implications. There Change very tightly to One Health. is overwhelming consensus on the com- ponents of One Health involving human In this session, we propose to discuss animals, non-human animals, and the in-depth, the importance of climate environment. As both human and non- change, considering the current global human animals fundamentally cannot awareness and movement around the exist outside of an environment, which subject, to One Health within the context they are an integral part of and share, of global pandemics. The discussion shared spaces need to be managed. will explore how the linkages extricated Therefore, an imbalance in activity by any between One Health and Climate Change party within a shared space puts that can be translated into global, regional and space in jeopardy of unsustainability. national policies and actions to promote a healthy and sustainable reconnected Destructive human and animal (often via future for our planet. humans) activity within the shared envi- PROGRAM 89

CHAIR

Gerald Haug German National Academy of Sciences Leopoldina | President | Germany

Australia Andrea Winkler Capon Roche PROGRAM, MON 26 Lancet Commission on One Health | Sabine Gabrysch Co-Chair | Charité–Universitätsmedizin Berlin | Germany Professor for Climate Change and Health | Germany

Sabine Andrea Gabrysch Winkler 90 MONDAY, OCTOBER 26

PANEL DISCUSSION

PD 19 ESSENTIAL SURGICAL

SAAL 2 | AMERICA AND TRAUMA CARE 16:00 – 17:30 An Integral Part of Universal Health Coverage

HOSTS

AO Alliance Foundation

Program in Global Surgery and Social Change of the Harvard Medical School

Although increasingly recognized as an and around 50 million permanently indivisible, indispensable part of Universal disabled persons per year. 90% of this Health Coverage, limited progress has mortality and morbidity occurs in LMICs. been made in recent years to advance To address this, we need integrated and surgical care around the world. Surgical holistic approaches to build up health conditions make up over ﬁve times the systems that includes increased emphasis mortality of HIV/AIDS, tuberculosis, and on surgical delivery, an emphasis that is malaria combined, yet funding for sur gical currently lacking. care remains inequitably small in terms of international funding. This despite the fact We must recognize that the old-fashioned that today, over ﬁve billion people remain myth that access to emergency and without access to safe surgical care. essential surgical care is a luxury item has been debunked. On the contrary, emer- The result: over 17 million preventable gency and essential surgical interventions deaths annually and 30% of the global are cost-e£ective and absolutely essential burden of disease is attributable to sur - for Universal Health Coverage. gical conditions. Furthermore, trauma and injury accounts for 5.8 million deaths PROGRAM 91

CHAIR

John G. Meara Georey Ibbotson Harvard Medical School | Global Surgery Foundation | Professor of Surgery | Executive Lead | United States of America Switzerland Jim Teri Harrison Reynolds

SPEAKERS

Jim Harrison Lubna Samad AO Alliance Foundation | Indus Health Network | African Regional Director | Director of Center for Essential Switzerland Surgical and Acute Care | Pakistan Ali Jafarian Ali Lubna

Tehran University of Medical Sciences H.E. Ifereimi Waqainabete Jafarian Samad PROGRAM, MON 26 (TUMS) | Former Chancellor | Fijian Government | Iran Minister for Health and Medical Services | Fiji Teri Reynolds World Health Organization (WHO) | Clinical Services and Systems– Integrated Health Services | Unit Head

John G. H.E. Ifereimi Meara Waqainabete 92 MONDAY, OCTOBER 26

WORKSHOP

WS 13 ‘BUILDING BACK BETTER’

SAAL 4 | AFRICA WITH SMART INVESTMENTS IN NCDS 16:00 – 17:30 A Post COVID-19 Imperative

HOSTS

NCD Alliance

Sanoﬁ

People living with noncommunicable At the same time, while health systems diseases (NCDs), such as cardiovascular are facing the most serious global pan- and respiratory diseases, diabetes or demic crisis in a century, the latter has cancer, have been at increased risk ampliﬁed the historical investment gap of severe illness and death due to the in NCDs and the underlying shortcomings COVID-19 pandemic, revealing how of health systems to respond to the vulnerable these groups are. The WHO healthcare need of people living with Rapid assessment of service delivery or at risk of NCDs. It has highlighted the for NCDs during the COVID-19 pandemic urgent need of political will to invest in has found that the COVID-19 pandemic NCD prevention and in strong health has ‘severely’ disrupted the delivery systems and primary healthcare as the of ser vices to prevent and treat NCDs best defence against outbreaks like in almost 80% of countries surveyed. COVID-19. Therefore, the interaction between COVID-19 and NCDs revealed how cru - In this context, this workshop will bring cial it is to address the underlying drivers the unique expertise of governments, of the NCD pandemic that are fuelling civil society, people living with NCDs and COVID-19 mortality. industry around the table to discuss the lessons learned from the crisis and the breadth of the long-term approach and investments needed to ensure a sustainable respond to NCDs. PROGRAM 93

CHAIR

Nina Renshaw The NCD Alliance | Director of Policy and Advocacy | Switzerland

SPEAKERS Funmi Marc-Antoine Adewara Lucchini Funmi Adewara Marc-Antoine Lucchini Mobihealth International | Sanoﬁ | Head of International Founder and CEO | General Medicine | United Kingdom France

Christopher Agbega Bente Mikkelsen People Living with NCDs (PLWNCDs) | World Health Organization (WHO) |

Representative | Division of Noncommunicable Diseases Christopher Bente

Ghana and Promoting Health through the Agbega Mikkelsen PROGRAM, MON 26 Life-course | Director Ricardo Baptista Leite UNITE | Founder and President | Portugal

Ricardo Nina Baptista Leite Renshaw 94 MONDAY, OCTOBER 26

WORKSHOP

WS 14 OVERCOMING CULTURAL BARRIERS

SAAL 5 | OCEANIA THROUGH RESPECT AND DIALOGUE 16:00 – 17:30

HOSTS

InterAcademy Partnership (IAP)

M8 Alliance

Sustainable peace is the central aim disciplines and cultures—and address of the Sustainable Development Goals how they can be overcome to achieve (SDGs) and a necessary basis for all progress towards the SDG objectives. SDGs, including “Good Health and Well- being”. The initiative “Respect and Dia- In response to the ongoing COVID-19 logue” by the InterAcademy Partnership pandemic, we have witnessed instances (IAP) intends to give science a stronger of dialogue and respect for each other’s voice and take more responsibility in this perspectives, and at times a noticeable regards. Many global crises are born or lack thereof. In this year’s session we worsened by the lack of comprehension, will look at these instances, and more and limited interest and courage to reach importantly what lessons are to be out across borders. Using health as an learned in the continuous e£orts to entry point, the “Respect and Dialogue” handle this pandemic and other global initiative wants to tackle barriers of di£er- health challenges. ent natures—gathering di£erent sectors, PROGRAM 95

CHAIRS

Edelgard Bulmahn Roberto Francesco Monti German Bundestag | Former Federal Respect and Dialogue | Minister and former Vice President | Senior Advisor | Germany Italy Edelgard Neera Bulmahn Tanden

SPEAKERS

Tolullah Oni Justin Vaïsse University of Cambridge | Paris Peace Forum | Senior Research Medical O±cer | Director-General | United Kingdom France

Clara Cruz Santos Moneef R. Zou’bi Roberto Francesco Justin

Coimbra University | InterAction Council | Monti Vaïsse PROGRAM, MON 26 Professor of Social Work | Science Advisor | Portugal Jordan

Neera Tanden Center for American Progress | President and CEO | United States of America

Tolullah Moneef R. Oni Zou’bi

Clara Cruz Santos 96 97

PROGRAM

TUESDAY, OCTOBER 27 98 TUESDAY, OCTOBER 27

PANEL DISCUSSION

PD 20 COVID 50/50: Live | SAAL 1 WOMEN LEADING IN CRISIS RUDOLF VIRCHOW A Gender Responsive Approach Overﬂow | SAAL 6 EUROPE

9:00 – 10:30 HOST

Women in Global Health

Gender equality makes global health communicate honestly with the public. stronger. This session will explore Yet, few women are included in health women’s leadership and gender-respon- security decision-making, including task sive health systems during COVID-19. forces, working groups, and political and Most countries report higher COVID-19 scientiﬁc committees for the pandemic mor tality amongst men than women response. The participation of women, but women face greater risks because their leadership and the breadth of their they are the majority of frontline health experience and perspectives is critical workers, are typically the primary care- to the response. Analysis of women givers of the sick, and have a greater leaders during COVID-19 has shown socioeconomic vulnerability. Women that women have used a more collabora- leaders tend to be decisive, listen to tive, transparent and whole of society expert evidence, focus on people and approach. PROGRAM 99

CHAIRS

Roopa Dhatt Sarah Hillware Women in Global Health | Women in Global Health | Executive Director | Deputy Director | United States of America United States of America Margaret Sarah Chan Hillware

SPEAKERS

Margaret Chan Elhadj As Sy Boao Forum For Asia | President Koﬁ Annan Foundation | Chair of the Board | Francesca Colombo Switzerland Organization for Economic Cooperation and Development (OECD) | Clare Wenham Francesca Elhadj As Head of the Health Division | London School of Economics and Colombo Sy France Political Science | Assistant Professor of Global Health Policy | Ester Cedeira Sabino United Kingdom University of São Paulo | Faculty of Medicine | Associate Professor | Brazil

Roopa Clare Dhatt Wenham PROGRAM, TUE 27 100 TUESDAY, OCTOBER 27

PANEL DISCUSSION

PD 21 DECADE OF ACTION:

SAAL 10 | ASIA ACCELERATING PROGRESS ON THE 9:00 – 10:30 HEALTH-RELATED SDGS AT COUNTRY LEVEL Leveraging the Global Action Plan for Healthy Lives and Well-being for All in countries in times of COVID-19

HOSTS

German Federal Ministry of Health (BMG)

World Health Organization (WHO)

By committing to the Global Action Plan tries under the auspices of the GAP, with for Healthy Lives and Well-being for All expressions of interest from many more. (GAP), the signatory agencies signaled This panel debate will present what coun- their readiness to better support countries are doing to get back on track and/or tries during the decade of action on the accelerate progress towards health-re- SDGs. COVID-19 has set countries back lated SDGs as they respond and recover on their path to achieving the health-relat- from COVID-19. It will feature representa- ed SDGs and has further emphasized the tives of countries engaged or interested importance of joint support to countries. in the implementation of the GAP and The GAP’s comparative advantage is to hear about their experiences so far and strengthen continuous, e£ective, long- what they expect from the GAP agencies term collaboration and alignment among in terms of joined-up support. The panel a set of UN and non-UN multilateral will share updates on the collaboration; agencies in support of countries’ nation- review lessons learned and challenges ally deﬁned needs, priorities and plans. encountered in the implementation of the Country ownership and leadership lie GAP to date and discuss how successful at the heart of GAP’s success and clear approaches could be replicated in more priorities for action to accelerate progress countries. The debate will also highlight towards the health-related SDGs have how other stakeholders at country level been identiﬁed by around a dozen coun- can engage and contribute to the process. PROGRAM 101

CHAIR

Suraya Dalil World Health Organization (WHO) | PHC Special Programme | Director

SPEAKERS Kwaku Fawziya Abikar Agyeman-Manu Nur Kwaku Agyeman-Manu Fawziya Abikar Nur Minister for Health | Ministry of Health | Ghana Minister of Health and Human Services Federal of the Republic of Somalia Cecilia Lodunu-Senoo Founder and Executive Director of Hope Malik Muhammad Saﬁ for Future Generations (HFFG) | Director General Health |

Ghana Ministry of National Health Services, Cecilia Malik Muhammad Regulation and Coordination, Govern- Lodunu-Senoo Saﬁ Muhsinzoda Gafur Muhsin ment | Ministry of Health and Social Protection | Pakistan First Deputy Minister | Tajikistan

Muhsinzoda Gafur Muhsin PROGRAM, TUE 27 102 TUESDAY, OCTOBER 27

PANEL DISCUSSION

PD 22 ACCESS TO ESSENTIAL MEDICINES

SAAL 2 | AMERICA IN LMICS 9:00 – 10:30 A Key Precondition to Achieving Universal Health Coverage

HOST

Medicines Patent Pool (MPP)

Limited access to essential medicines of medicines could make the implementa- is one of the key barriers to health. tion of Universal Health Coverage (UHC) This is particularly true for the majority una£ordable. of low-and middle-income countries (LMICs). The barriers are varied and The answer to this challenge is to make include weak health systems, no or lack medicines available and a£ordable, but of proper infrastructure, insu±cient the next question is how. A number of numbers of health workers, insu±cient access models have been tried, including knowledge among health workers, no voluntary public health licensing, dona- surveillance systems, lack of diagnostics. tion programs, tiered pricing, bilateral Price, of course, is a key barrier. deals between originators and generic companies, and as a last resort compul- The price of patented medicines is be- sory or government licensing. The appro- coming an increasing challenge in all priateness of each model will depend on countries, but in LMICs the proportion of the speciﬁc circumstances but all should healthcare spend on medicines is higher, be judged against the major public health at least a quarter and up to 67% of the standards of transparency, sustainability, entire healthcare budget, and this con- and beneﬁt. tinues to increase. As a result, the price PROGRAM 103

CHAIR

Charles Gore Medicines Patent Pool (MPP) | Executive Director | United Kingdom

SPEAKERS Graham Maurine Cooke Murenga Graham Cooke Mariângela Simão Imperial College | World Health Organization (WHO) | Wright-Fleming Institute | NIHR Research Assistant Director General, Professor of Infectious Diseases | Access to Medicines, Vaccines United Kingdom and Pharmaceuticals

Jayasree K. Iyer Marisol Touraine Access to Medicine Foundation | Unitaid | Charles Mariângela Executive Director | Chair of the Executive Board Gore Simão The Netherlands

Maurine Murenga Lean on Me Foundation | Executive Director | Kenya

Jayasree K. Marisol Iyer Touraine PROGRAM, TUE 27 104 TUESDAY, OCTOBER 27

WORKSHOP

WS 15 CARDIOVASCULAR HEALTH For the Many and the Few SAAL 4 | AFRICA 9:00 – 10:30

HOST

Max Delbrück Center for Molecular Medicine (MDC)

Cardiovascular disease represents one paramount for the development of per- of the major threats to human health. sonalized and highly e£ective/tailored As longevity and prosperity increase treatments. From a population perspec- globally, changing nutrition and a more tive, however, understanding global se dentary life style drive increasing risk correlations, risk factors and preventive for acute and chronic cardiovascular opportunities as well as generic treat- disease. Whilst the costs for societies are ment opportunities for this systems-wide steadily growing, research budgets and pathology, with particular attention to the the emergence of new therapies do not di£ering conditions in the regions of the keep pace. Consequently, the medical world appears the most urgent demand. need and societal importance to advance This workshop therefore aims to portray both our understanding of fundamental on the one hand state-of-the art science pathomechanisms and to develop e£ec- approaches that unravel the epidemiol- tive means to prevent and treat a ‘pan- ogy and population genetics/genomics, demic’ of heart failure and multiorgan risk factors and global treatment options damage associated with poor microvas- to benefit ‘the many’ and on the other cular health is greater than ever before. hand those that dig deeper into the From the perspective of the individual, disease mechanisms of the individual understanding the particular link between to optimally treat ‘the few’.Perspectives genetic predisposition, epigenetic im- from international medical experts, printing of environmental and lifestyle epidemiologists, experimental researchers related influences on cardiovascular and pharma industry leaders will shape tissues, and the specific manifestation the discussion on emerging issues in or phenotypic spectrum appears to be cardiovascular health research. PROGRAM 105

CHAIRS

Holger Gerhardt Joël Ménard Max Delbrück Center for University of Paris Descartes | Molecular Medicine in the Emeritus Professor of Public Health | Helmholtz Association (MDC) | France Head of Integrative Vascular Biology | Ann Joël Aerts Ménard Germany

SPEAKERS

Holger Karen Gerhardt Sliwa-Hahnle PROGRAM, TUE 27 106 TUESDAY, OCTOBER 27

WORKSHOP

WS 16 DEVELOPING STRATEGIES

SAAL 5 | OCEANIA FOR FIGHTING COVID-19 9:00 – 10:30 AROUND THE WORLD (PART 1)

HOST

German Federal Ministry for Economic Cooperation and Development (BMZ)

Even pandemics with global dimensions panel will identify, present and discuss have local and regional origins. This high- both technical principles and concrete level event under the patronage of the operational measures from practice. German Federal Ministry for Economic As a result, a range of recommendations Cooperation and Development (BMZ) for future action will be formulated. and Charité Universitätsmedizin Berlin Addressing the One Health approach, is therefore intended to gather and which especially in the course of the exchange international experience from current pandemic, as multisectoral and the ﬁght against these kinds of risks. holistic approach, has gained increasing An international and multisectoral expert attention, will be one practical example of the session. PROGRAM 107

CHAIR

Maria Flachsbarth Federal Ministry for Economic Cooperation and Development (BMZ) | Parliamentary State Secretary | Germany Christian Thomas C. Drosten Mettenleiter

SPEAKERS

Christian Drosten Thomas C. Mettenleiter Charité–Universitätsmedizin Berlin | Friedrich Loe¾er Institute (FLI) | Institute of Virology Campus Charité President | Mitte | Director of the Institute | Germany Germany Gerd Müller Monique Gerd Monique Eloit Federal Ministry for Economic Eloit Müller OIE–World Organisation for Cooperation and Development (BMZ) | Animal Health | Director-General | Federal Minister for Economic France Cooperation and Development | Germany

Maria Flachsbarth PROGRAM, TUE 27 108 TUESDAY, OCTOBER 27

PANEL DISCUSSION

PD 23 GOARN 2020: CHANGING THE FACE Live | SAAL 1 OF OUTBREAK SUPPORT RUDOLF VIRCHOW 20 Years of Global Outbreak Alert and Response Network Overﬂow | SAAL 6 EUROPE

11:00 – 12:30 HOSTS

Global Outbreak Alert and Response Network (GOARN)

Robert Koch Institute (RKI)

World Health Organization (WHO)

In April 2000, outbreak response part- established. The numbers of partners and ners—UN agencies, international and stakeholders has increased dramatically Non-Governmental Organizations, public and international coordination and fund- health agencies, technical networks and ing has become more complex. In all of academia—were brought together by this, keeping the a£ected communities at WHO to set up the Global Outbreak the centre of the response, has not always Alert and Response Network (GOARN). been easy, or successful.

Based on experience in the field, partners The COVID-19 pandemic has a devastat - recognized the need to strengthen ope- ing impact on health, and on society; rational and technical coordination, and and presents unprecedented challenges rapid deployment of multidisciplinary for countries, international coordination, multi-agency response teams to support and solidarity. GOARN partners and local communities and health authorities. technical networks are heavily involved directly in domestic and international Over the past 20 year, achievements response to the COVID-19 pandemic. have been made in responding to major outbreak; and major challenges has been This panel debate will bring together identified. In addition, the global land- representatives of GOARN partners and scape of outbreak response has become networks to reflect the highly intercon- more multisectoral, with new regulations, nected multidisciplinary and operational agencies and networks having also been nature of outbreak response. PROGRAM 109

Most importantly, the panel will For GOARN, this panel will be discuss the major operational part of a developing process gaps and technical challenges of review and improvement in that have been exposed by the technical and operational areas pandemic; the steps needed of global pandemic prevention, now as our pandemic response preparedness, and response, Omar Dale Andrew Michael evolves, and to accelerate na- and will help direct how GOARN Abdi Fisher Ryan tional and global preparedness will contribute to the COVID-19 and rapid response for further pandemic response, and to emerging disease threats. future similar events.

CHAIRS Emanuele Johanna Amadou Dale Andrew Fisher Johanna Hanefeld Capobianco Hanefeld Sall World Health Organization London School of Hygiene and (WHO) | Global Outbreak Alert Tropical Medicine | Lead LSHTM and Response Network | Berlin and Associate Professor Chair Health Policy and Systems | Germany

Xiaoping Rebecca Micaela SPEAKERS Dong Martin Seraﬁni PROGRAM, TUE 27

Omar Abdi Xiaoping Dong UNICEF | Chinese Center for Disease Michael Ryan Deputy Executive Director Control and Prevention World Health Organization Emergencies for Programmes (China CDC) | Center for Global Programm (WHO) | Executive Director Public Health | Director | China Emanuele Capobianco Amadou Sall International Federation of Rebecca Martin Institut Pasteur de Dakar | Director | Senegal Red Cross and Red Crescent Centers for Disease Control and Societies (IFRC) | Prevention (CDC) | Center for Micaela Seraﬁni Director Health and Care | Global Public Health | Director | Médecins Sans Frontières (MSF)| Task Force Switzerland United States of America Leader–Access to COVID-19 Tools | Germany 110 TUESDAY, OCTOBER 27

PANEL DISCUSSION

PD 24 MIGRANT AND

SAAL 10 | ASIA REFUGEE HEALTH 11:00 – 12:30 Towards an Agenda of Solutions

HOSTS

M8 Alliance

Sapienza University of Rome

Global migration is one of the most as education, health care, employment compelling human experiences of our and freedom of movement. Refugees time. It has increased as a result of con- and migrants remain among the most flict, persecution, environmental degra- vulnerable members of society despite dation and change, and a profound lack existing and ratified international human of human security and opportunity. The rights standards and conventions that IOM estimates that currently 278 million protect the rights of refugees and mi- people (approximately 1 in every 30) grants—including their right to health— are international migrants. Global dis- many lack access to health services and placement reported by UNHCR includes financial protection in health for them- nearly 80 million being forced from their selves and their family members. They homes as a result of persecution, con - often su£er from discriminatory migra- flict or generalized violence. The number tion policies and have limited access to of refugees is estimated currently at health and social services despite being more than 26 million, 68% coming from exposed to many health risks, including Afghanistan, Myanmar, South Sudan, exploitation, dangerous working and the Syrian Arab Republic and Venezuela. substandard living conditions. The UNHCR also has information for 3.9 million stateless people, although COVID-19 has shown us that our health there may be many more denied natio- system is as strong as our weakest link. nality and access to basic rights such Investing in the health of refugees and PROGRAM 111

migrants is therefore key to not only In this session, after an update from to controlling and managing the pan- the European Commissioner for Home demic but addressing the health needs A£airs about the recent regulations of of migrants improves their health and the European Union related to immigra- integration and advances global public tion, well known experts in the ﬁeld will health and UHC. present and discuss migrant and refugee Ibrahim Luciano health issues in Europe and beyond. Abubakar Saso

CHAIR

Luciano Saso Sapienza University of Rome | Faculty of Pharmacy and Medicine | Vice-Rector for European University Networks |

Italy Ylva Akihiro Johansson Seita

SPEAKERS

Ibrahim Abubakar Akihiro Seita UCL Institute for Global Health (IGH) | UNRWA | Health Department | Director | Director of the Department United Kingdom Santino Severoni Ylva Johansson World Health Organization (WHO) | Dominique Santino Kerouedan Severoni PROGRAM, TUE 27 European Commission | Director of Health European Commissioner for and Migration Program Home A£airs | Belgium

Dominique Kerouedan Sciences Po Paris | Concentration in Global Health | Founder, Lecturer and Scientiﬁc Advisor | France 112 TUESDAY, OCTOBER 27

PANEL DISCUSSION

PD 25 WOMEN’S HEALTH

SAAL 2 | AMERICA IN THE COVID-19 ERA 11:00 – 12:30 Can Lessons Learnt from the COVID-19 Crisis Catalyze a Paradigm Change in Healthcare?

HOSTS

Charité – Universitätsmedizin Berlin

M8 Alliance

Giving primary prevention a key role is In the post COVID-19 era, hospital care one of the main lessons that can already systems will be overwhelmed because of be drawn from the management of major backlogs in the management of the COVID-19 health crisis. High popula- non-COVID-19 related health conditions. tion acceptance of primary prevention This will be most relevant in low- and measures and high-quality primary care middle-income countries. It is the right is essential to keep hospital care systems timing to use the momentum of the functional and to save lives. Only collec- COVID-19 crisis for a paradigm change tive behavior changes can lead to sub- in health systems design where primary stantial health impact. In analogy to prevention and innovative primary health women cancers and NCD in general, care systems will play a prominent role primary prevention such as HPV vacci- by building upon experiences from the nation and screening programs by inno- women health agenda. vative testing technologies are known to be e£ective. However, this will reduce The mandate given to national govern- hospital care workload only if collective ments by the UN General Assembly to health behavior changes are achieved develop stepwise universal health cover- and high-quality primary care services age is a great challenge and requires an are accessible for all. adaptation of health agendas. The post PROGRAM 113

COVID-19 era is a unique opportunity enable the development of a global to increase aid e£ectiveness by over- community of healthcare providers coming institutional barriers between who will lead the necessary changes the operating health agencies national in primary care level and where women governments, NGOs, and academia. health will spearhead health system

Innovation in knowledge transfer will changes. Teresa Jalid Graham Sehouli

CHAIRS

Germany Germany Shannon Princess Nothemba Hader Simelela

SPEAKERS

Shannon Hader Princess Nothemba Simelela Anja Andreas Langenbucher Ullrich PROGRAM, TUE 27 Joint United Nations Programme World Health Organization (WHO) | on HIV and AIDS (UNAIDS) | Special Advisor to the Director-General, Deputy Executive Director Strategic Programmatic Priorities 114 TUESDAY, OCTOBER 27

WORKSHOP

WS 17 FIGHTING FALSIFIED

SAAL 4 | AFRICA AND SUBSTANDARD MEDICINES 11:00 – 12:30 DURING THE COVID-19 CRISIS Increased Demand and Interrupted Supply Chains Oer Opportunities for Counterfeiters

HOSTS

Association of Research-based Pharmaceutical Companies (vfa)

German Federal Ministry for Economic Aairs and Energy (BMWi)

The fight against falsified and substand- and supply chains of medicines world- ard medicines in low- and middle-income wide, and some countries stopped the countries (LMICs) is a major challenge. export of medicines. Newly developed With constrained access to essential medicines and vaccines against COVID-19 medicines, weak technical capacity for will be in very high demand. All this medicine quality assurance and control, creates increased opportunities for the and challenges in appropriate govern- distribution of falsified medicines by ance both in health care facilities and in criminals. national medicines regulatory authorities, many LMICs show the conditions In this session we will try to assess the which WHO has identified as favoring the situation from the viewpoints of di£erent occurrence of substandard and falsified stakeholders, and discuss possible strate- medicines. Additionally, the COVID-19 gies to counteract the proliferation of crisis led to a disruption of the production falsified medicines, with a focus on Africa. PROGRAM 115

CHAIR

Lutz Heide Eberhard Karls University Tuebingen | Professor of Pharmaceutical Biology | Germany

Moji Christianah Pierre Claver Adeyeye Kayumba SPEAKERS

Lutz Sachiko Heide Ozawa PROGRAM, TUE 27 116 TUESDAY, OCTOBER 27

WORKSHOP

WS 18 DEVELOPING STRATEGIES

SAAL 5 | OCEANIA FOR FIGHTING COVID-19 11:00 – 12:30 AROUND THE WORLD (PART 2)

HOST

German Federal Ministry for Economic Cooperation and Development (BMZ)

Even pandemics with global dimensions both technical principles and concrete have local and regional origins. This high- operational measures from practice. level event under the patronage of the As a result, a range of recommendations German Federal Ministry for Economic for future action will be formulated. Cooperation and Development (BMZ) Addressing the One Health approach, and Charité Universitätsmedizin Berlin which especially in the course of the is therefore intended to gather and current pandemic, as multisectoral and exchange international experience from holistic approach, has gained increasing the ﬁght against these kinds of risks. attention, will be one practical example An international and multisectoral expert of the session. panel will identify, present and discuss PROGRAM 117

CHAIR

Maria Flachsbarth Federal Ministry for Economic Cooperation and Development (BMZ) | Parliamentary State Secretary | Germany Andrea John Ammon Nkengasong

SPEAKERS

Andrea Ammon John Nkengasong European Centre for Disease Prevention Africa Centres for Disease Control and Control (ECDC) | Director | and Prevention | Director | Sweden Ethiopia

Gerd Müller Soumya Swaminathan Maria Soumya Federal Ministry for Economic World Health Organization (WHO) | Flachsbarth Swaminathan Cooperation and Development (BMZ) | Chief Scientist Federal Minister for Economic Elhadj As Sy Cooperation and Development | Koﬁ Annan Foundation | Germany Chair of the Board | Switzerland

Gerd Elhadj As Müller Sy PROGRAM, TUE 27 118 TUESDAY, OCTOBER 27

PANEL DISCUSSION

PD 26 BMJ COLLECTION—WOMEN’S HEALTH Live | SAAL 1 AND GENDER INEQUALITIES RUDOLF VIRCHOW Lessons and Emerging Priorities 25 years after the Beijing Platform for Action Overﬂow | SAAL 6 EUROPE

13:00 – 13:30 HOSTS

The BMJ

UNU International Institute for Global Health (UNU-IIGH)

World Health Organization (WHO)

The 25 years since the visionary Beijing At the same time, the concerns outlined Declaration and Platform for Action for 25 years ago remain deafeningly relevant Women have seen dramatic changes for women’s and girls’ health. Millions globally. While there has been important, of women continue to have an unmet albeit chequered, progress on some need for contraceptives, for example, fronts, new challenges have emerged, and adolescent girls still lack su±cient including the current COVID-19 pandemic. information or quality services to prevent Demographic, epidemiological, techno- pregnancies, STIs or HIV. This unﬁnished logical and socio-economic transitions agenda highlights the lack of real poli - have evolved the nature of risks and tical commitment to women’s health and drivers of women’s health, their access gender equality, as well as the power of to healthcare services, experience of ill the conservative backlash. The COVID-19 health and quality of life. Climate change, pandemic has heightened many of migration, and humanitarian crises are women’s health risks, in particular for precipitating new risk factors. Rapid women healthcare providers, survivors urbanization, greater economic partici- of violence, and women with unintended pation of women and rising socio-eco- pregnancies. It has also exacerbated nomic inequalities coupled with advances the burden of formal and informal care in health and medical technologies are placed on women and girls. This session a£ecting women’s health and underlying will draw on evidence and lessons on gender inequalities in di£erent ways. advancing women’s health since Beijing PROGRAM 119

to rethink how to better meet their needs, Nations University and the World Health now and in a post-COVID-19 world. Organization, panelists will reﬂect on progress, emerging opportunities, risks, Based on a series of papers commis- and a forward-looking agenda for women sioned by the British Medical Journal, as and health towards 2030 and beyond. part of a joint collection with the United Pascale Princess Nothemba Allotey Simelela

CHAIR

Princess Nothemba Simelela World Health Organization (WHO) | Special Advisor to the Director-General, Strategic Programmatic Priorities

SPEAKERS Claudia Paul Garcia-Moreno Simpson Pascale Allotey Paul Simpson United Nations University | The British Medical Journal | International Institute for Global Health International Editor | (UNU-IIGH) | Director of the Institute | United Kingdom Malaysia Lavanya Vijayasingham Claudia Garcia-Moreno United Nations University | World Health Organization (WHO) | International Institute for Global Health | Asha Lavanya Department of Sexual and Reproductive Postdoctoral fellow | George Vijayasingham PROGRAM, TUE 27 Health and Research | Unit Head Malaysia

Asha George University of the Western Cape | School of Public Health | Professor | South Africa 120 TUESDAY, OCTOBER 27

KEYNOTE

KEY 05 PARTNERSHIP FOR THE GOALS SAAL 1 United Nations 75th Anniversary RUDOLF VIRCHOW 14:00 – 15:30

HOSTS

German Federal Ministry of Health (BMG)

World Health Organization (WHO)

Achieving the Sustainable Development The UN General Assembly 75 has seen Goals, our shared vision for the future, extraordinary commitments expressed by will require cooperation across borders, many leaders for SDG achievement and sectors, and generations. Due to COVID- global health. The warnings by the UN 19 we are witnessing a roll back in goal Secretary General and the Director-Gen- achievement—related to health and to eral of the World Health Organization many social determinants and especially (WHO) on the need to support for global for women and children. Now we need cooperation and multilateralism must be collective action and solidarity more than heeded at a time when in many countries ever, and a clear commitment to global public trust in traditional institutions is common goods. This is what the United in decline and human rights are disre- Nations (UN) stands for. New ground- garded. As relations between countries breaking partnerships—such as COVAX come under strain, dialogue and action and the ACT-Accelerator are being on global issues—nearly all of which developed and can serve as examples directly and indirectly a£ect health— that it can be done. could not be more urgent. How do we support the UN in its aim to build a global vision of 2045 (its centenary) and support enhanced international cooperation to realize that vision. PROGRAM 121

CHAIR

Bernhard Schwartländer World Health Organization (WHO) | Chief of Sta£

SPEAKERS Inger Rafael Mariano Ashing Grossi Inger Ashing Rafael Mariano Grossi Save the Children International | CEO | International Atomic Energy Agency | United Kingdom Director-General

Michelle Bachelet Natalia Kanem United Nations | United Nations Population Fund High Commissioner for Human Rights (UNFPA) | Executive Director

Seth Berkley Michelle Natalia Bachelet Kanem Gavi, the Vaccine Alliance | CEO | Switzerland

Seth Bernhard Berkley Schwartländer PROGRAM, TUE 27 122 TUESDAY, OCTOBER 27

PANEL DISCUSSION

PD 27 DIGITAL HEALTH & AI

SAAL 6 | EUROPE FOR PANDEMIC PREPAREDNESS 14:00 – 15:30 United Nations A Post Novel Coronavirus Pneumonia (COVID-19) and Chronic Non-Communicable Disease (NCD) Pandemic Framework for Global Action in the Digital Economy & Society 2030

HOST

Global He@lth 2030 Innovation Task Force

Digital Health and Artificial Intelligence All lack global standardization today, and (AI) are the future of health protection, COVID-19 has shockingly laid bare the delivery and emergency management. fragmentation and chronic under-funding Like HIV/AIDS in 2000 and the Ebola of national health systems across the and Zika outbreaks in 2014 and 2016, the world. Employing winning strategies with novel coronavirus pneumonia (COVID-19) amplified ambition needs to be defined pandemic is a defining moment in global and disseminated for shared use at scale health security leadership. Marshalling a in the current planetary pandemic and concerted global and regional e£ort for beyond. COVID-19 is much more than a risk, resilience, response, reconstruction wake-up call for systemic and sustainable and recovery must this time include full digital health ecosystem transformation. multi-stakeholder engagement as essen- It has cruelly exposed the chasm in mind- tial to pandemic preparedness in the digital sets and modalities between not only the era. This will extend to future essential global health and financial communities, innovative funding mechanisms, R&D net- but also between global technology and works and Centers of Excellence. China’s pharmaceuticals industries. WHO, UN COVID-19 response employed a strength- Member States, civil society and the ened national health system after the private sector must radically rethink their SARS 2003 and H1N1 2009 outbreaks, anemic and anachronistic stratagems and widespread use of ubiquitous mobile for pandemic preparedness, UHC 2030 and digital health and finance technologies and Chronic NCDs in the Digital Economy in government and business partnership. & Society of the 21st Century. PROGRAM 123

CHAIR

Denis Gilhooly Global He@lth 2030 Innovation Task Force | CEO | United States of America

SPEAKERS George F. Joann Gao O’Brien George F. Gao Bernd Ohnesorge Chinese Center for Disease Control Siemens Healthineers AG | and Prevention | Director | President EMEA | China Germany

Florence Gaudry-Perkins Soumya Swaminathan Digital Health Partnerships (DHP) | World Health Organization (WHO) |

Founder & CEO | Chief Scientist Florence Bernd France Gaudry-Perkins Ohnesorge

Joann O’Brien TM Forum | Digital Ecosystems | Vice President | United States of America

Denis Soumya Gilhooly Swaminathan PROGRAM, TUE 27 124 TUESDAY, OCTOBER 27

WORKSHOP

WS 19 A EUROPEAN UNION

SAAL 4 | AFRICA IN HEALTH 14:00 – 15:30 Role of a European Council for Health Research

HOSTS

Charité – Universitätsmedizin Berlin

M8 Alliance

In the wake of COVID-19, the need for MEPs and major organizations have concerted action for health in Europe led called for European leadership in health, the European Commission to propose addressing inequity in Europe and an ambitious program for health for bridging health, research and innovation. 2021–2028. There is little doubt that to A European Council for Health Research address the needs in health, whether as a multi-stakeholder platform could be pandemic preparedness, chronic disease, a ﬁrst step. Panel members will discuss child health or environment, global and potential scenarios on the road to a multi-sectoral collaboration is necessary. European Health Union. PROGRAM 125

CHAIRS

Laurent Degos Karin R. Sipido French Academy of Science | KU Leuven | Professor of Medicine and Corresponding Member | Head of Experimental Cardiology | France Belgium Laurent Hans Degos Hofstraat

SPEAKERS

Christian Drosten Susanna Palkonen Charité–Universitätsmedizin Berlin | EFA–European Federation of Institute of Virology Campus Charité Allergy and Airways Diseases Patients’ Mitte | Director of the Institute | Associations | Director | Germany Belgium Christian Karin R. Hans Hofstraat John-Arne Røttingen Drosten Sipido Philips Research | Chief Executive | Vice President Research | Research Council | The Netherlands Norway PROGRAM, TUE 27 126 TUESDAY, OCTOBER 27

WORKSHOP

WS 20 NEW VOICES

SAAL 5 | OCEANIA IN GLOBAL HEALTH 14:00 – 15:30 Perspectives and Responses of Young Scientists to the Coronavirus Pandemic

HOST

Global Young Academy (GYA)

Members of Young Academies and talk will provide a deﬁned input to create similar early to mid-career scientist a common basis for discussion, which will networks share their perspectives and be a key element of the session to hear responses to the coronavirus pandemic. New Voices in Global Health among the Speakers will give a concise input in the audience and speakers. format of a lightning talk. Each lightning PROGRAM 127

CHAIRS

SPEAKERS

Monir Ahmed Abul Bashar Mir Md Khademul Islam Global Young Academy | National Young Academy Shymaa Stefan Arya Shalini Qassim University | of Bangladesh | Enany Kohler Subash Department of Medical Labora- University of Dhaka | Department tories | Assistant Professor | of Genetic Engineering and Bio - Saudi Arabia technology | Associate Professor | Bangladesh Shymaa Enany Egyptian Young Academy Paramdeep Singh of Sciences | Indian National Young Academy

KEYNOTE

KEY 06 ACCELERATING THE SAAL 1 SDG 3 GLOBAL ACTION PLAN RUDOLF VIRCHOW 16:00 – 17:30 FOR HEALTH AND WELL-BEING

HOSTS

German Federal Ministry of Health (BMG)

World Health Organization (WHO)

The Global Action Plan for Healthy Lives support to countries and forums for and Well-Being for All brings together international commitments to health, 12 multilateral health, development, such as the UN High-Level Meeting on and humanitarian agencies to better Universal Health Coverage and the support countries and accelerate pro- Astana Conference on Primary Health gress towards health-related Sustainable Care. At the World Health Summit, Development Goals. Under the Global representatives of the signatory agencies Action Plan, the agencies are better will present updates on the Action Plan, aligning their work to reduce ine±cien- and its challenges and successes. cies and provide more streamlined PROGRAM 129

CHAIR

Ilona Kickbusch The Graduate Institute of International and Development Studies | Global Health Center | Chair of the International Advisory Board | Switzerland Tedros Adhanom Muhammad Ghebreyesus Pate

SPEAKERS

Tedros Adhanom Ghebreyesus Muhammad Pate World Health Organization (WHO) | Global Financing Facility (GFF) | Director-General Director | United States of America Jeremy Farrar

Wellcome Trust | Director | Peter Sands Jeremy Peter United Kingdom The Global Fund to Fight AIDS, Farrar Sands Tuberculosis and Malaria | Henrietta H. Fore Executive Director | United Nations Children’s Fund (UNICEF) | Switzerland Executive Director Marisol Touraine Unitaid | Chair of the Executive Board

Henrietta H. Marisol Fore Touraine PROGRAM, TUE 27

Ilona Kickbusch

GENERAL INFORMATION

GENERAL INFORMATION 132 GOOD TO KNOW

ACCESS TO THE VENUE CATERING DIGITAL PARTICIPATION

Participants and speakers must Food and beverage distribution You are cordially invited to take part present a valid photo ID to pick up during break times follows the in the World Health Summit 2020 their badges. Please be advised that COVID-19 hygiene guidelines. digitally: bags may be inspected for security All sessions will be broadcast online reasons. We kindly ask that you CLOAKROOM with Q&A opportunities for all refrain from bringing luggage to digital participants. the venue. Badges should be worn The cloakroom is located to the at all times, and are required to left of the entrance and is free of • Access is possible worldwide enter all sessions. charge. via PC, tablet, smartphone • High reliability through load- Please note: Due to COVID-19 only COVID-19 REGULATIONS balancing features a limited number of participants for low-bandwidth situations is permitted at the venue and in The organizers comply with all • Interactive formats through the session rooms. All sessions will o±cial stipulations, implement Q&A function, screen, and be broadcast online; the links are necessary measures, and follow all document sharing available in the program. rules regarding hygiene, protective • One proper entry link per session gear, distancing, number of parti- available in the program: CAPACITY LIMITS cipants, etc. www.conference. worldhealthsummit.org/ Due to the pandemic-induced • Hygiene: Disinfectants are avail- Program/WHS2020 regulations regarding distancing able throughout the venue and hygiene, the capacity of session • Distance: At least 1,50 meter EMERGENCY NUMBERS (Germany) rooms and the venue as a whole is between individual participants limited. The organizers reserve the in seating Ambulance/Fire: 112 right to refuse access to the venue • Masks: It is mandatory to wear Police: 110 or to session rooms if the maximum a mouth and nose protection in capacity has been reached. We the entire venue and at all times. INTERNET follow the “ﬁrst come—ﬁrst served” principle throughout the conference WiFi is available throughout and in all sessions. the venue.

Network: WorldHealthSummit Password: #WHS2020 GOOD TO KNOW 133

MEDIA PARKING SOCIAL MEDIA

The World Health Summit is fully Parking is available at the venue in #WHS2020 open to the press, but due to an underground lot. Follow us on COVID-19, places for journalists www.twitter.com/worldhealthsmt on-site are limited. Press badges PEOPLE WITH DISABILITIES www.facebook.com/ are available at the media desk at worldhealthsummit the entrance of the venue. Please The venue is accessible to partici- www.linkedin.com/company/ present a valid photo ID. The press pants with disabilities. If you require worldhealthsummit badge must be worn at all times speciﬁc accommo dations, please www.youtube.com/user/ during the World Health Summit. inform summit sta£: WorldHealthSummit1 [email protected] End of Accreditation for on-site participation: Wednesday, Oct.21: SPEAKER CENTER PROGRAM CHANGES www.worldhealthsummit.org/ media/accreditation.html The speaker center is located on The program is subject to changes the upper level. Speakers must bring Digital participation is possible due to unforeseen circumstances. any audio-visual materials they without accreditation via: Please check the interactive online require to the speaker center prior www.worldhealthsummit.org or program planner on our website to their session. www.conference.worldhealthsummit. for regular updates. org/Program/WHS2020. www.conference. Presentations cannot be run from worldhealthsummit.org/ personal laptop computers in the Press information: Program/WHS2020 session rooms. www.worldhealthsummit.org/ media/presskit.html The speaker center is open during REGISTRATION the following times: Press contact: communications@ The registration desk is open during Sunday, October 25 10:00 – 18:00 worldhealthsummit.org the following times: Monday, October 26 8:00 – 18:00 Tuesday, October 27 8:00 – 18:00 Sunday, October 25 9:00 – 17:30 LOST AND FOUND Monday, October 26 8:00 – 18:00 TAXI Tuesday, October 27 8:00 – 18:00 Lost items can be collected at the registration counter during the Taxi Berlin +49 30 202020 World Health Summit. After the Taxi Würfelfunk +49 30 210101 summit, unclaimed items will be held Taxi Funk +49 30 443322 by the venue for a limited time only. 134 CITY OF BERLIN

BERLIN HEALTH EXCELLENCE— EXPERTISE AND

CUTTING-EDGE MEDICINE Humboldtforum MADE IN BERLIN

Berlin’s success as a health capital reﬂects a 300-year tradition as a healthcare and scientiﬁc centre. More than a dozen Nobel Prize winners worked here, including researchers such as Rudolf Virchow and Robert Koch. One of Berlin’s most famous medical institutions is the renowned Charité, Europe’s largest university hospital and one of Germany’s leading hospitals. World-renowned scientists of the Charité cooperate closely with recognised research organisations such as the Massa- chusetts Institute of Technology in Boston. The Berlin Delphi-Saal Institute of Health is an important third pillar alongside health care and the medical faculty. The aim is to trans- Many more hospitals and doctor’s surgeries could be fer the research results from the laboratory to clinical mentioned, as all of them o£er top-class medical treat- care as quickly as possible and thus to provide patients ment and provide medical experts of all disciplines. in Berlin with the best possible care. Medical care at the highest level requires a strong Other outstanding hospitals are the German Heart collaboration between scientists and practitioners. Centre—a top-level hospital for heart and vascular Berlin is a leading centre of science and research in diseases under the leadership of world famous heart Europe, especially focusing on medicine. Four public surgeon Professor Dr. med. Volkmar Falk, or Vivantes— universities, the Charité teaching hospital, seven with its nine clinics and several rehabilitation centres universities of applied sciences and over 30 private being Germany’s largest municipal hospital group. universities o£er teaching and research facilities for people from all over the world. Germany’s most important research organizations such as the Fraun- hofer-Gesellschaft or the Max Planck Society are More information at represented in Berlin, and successful technology parks www.berlin-health-excellence.com like the tech-hub Adlershof or biotech park Campus Berlin-Buch are established here. CITY OF BERLIN 135

For the latest information, see www.visitBerlin.com

BERLIN— CAPITAL OF CULTURE

Apart from the excellent quality of medical services in Berlin, the city’s many green spaces, parks and leisure amenities o£er high-quality relaxation to support a patients’ recovery. The German capital is also well known for its diversity of cultural events and venues.

Berlin’s museums and galleries o£er everything, from ancient art to world-class old masters and avant- held various exhibitions to celebrate this centenary, garde design, from classical opera to musicals and pop including Chaos & Renewal—Berlin 1920/2020 in the concerts. Culture and art enthusiasts can admire out- Märkisches Museum and 100 Years of (Greater) Berlin: standing works from down the centuries to today’s An Uncompleted Project in the Kronprinzenpalais. cutting-edge art styles. The ﬁve museums on the These exhibitions not only showcase the historical Museum Island in the historic city centre are home to event, but create an arc to present-day Berlin and world-renowned collections. Here, you can admire present visions of the future city. exceptional treasures and artefacts from 3,000 years In December this year, the new Humboldt Forum in the of human history—for example, in the Neues Museum reconstructed Berlin Palace is opening its ﬁrst sections with the famous bust of Nefertiti. In contrast, the to the public, including an exhibition on the history of nearby Martin-Gropius-Bau presents contemporary art. the site and the Schlosspassage with the museum shop. Berlin is one of the world’s few cities to have three The Asian Art Museum and the Ethnological Collections opera houses: Classical music lovers can choose from are scheduled to open in 2021. Not only will the new a repertoire of famous works or new and experimental Humboldt Forum then be showing world-class cultural operas. Apart from these opera houses, the city’s eight works, but this will also complete Berlin Mitte, the large orchestras, including the world-famous Berliner cultural heart of the city. Philharmoniker conducted by Kirill Petrenko, also make During the corona pandemic, the health of Berlin’s for high-class musical enjoyment. guests is a top priority. Museums, concert halls and This year Berlin marked a very special centenary. In opera houses as well as meeting venues have all devel- 1920, modern Berlin was created more or less overnight. oped comprehensive and detailed hygiene concepts. Formed from eight towns and numerous local authori- Thanks to time slot tickets bookable online and the ties, Greater Berlin became the world’s second largest generous spaces in these venues, guests can enjoy metropolitan city after New York. In 2020, Berlin has a relaxed cultural experience. 136 WORLD HEALTH SUMMIT LEADERSHIP

PRESIDENTS SCIENTIFIC COMMITTEE

2020 MEMBERS

The World Health Summit Scientiﬁc Committee consists of the M8 Alliance Executive Committee (see page 140) and selected members of the World Health Summit Council.

CHARLES IBINGIRA DETLEV GANTEN TILL BÄRNIGHAUSEN International President Founding President Director 2020 & 2021 World Health Summit Heidelberg Institute Principal Charité –Universitäts- of Global Health, Makerere University medizin Berlin CO-CHAIRS Germany College of Health Sciences, Germany Uganda

STEFAN KAUFMANN DETLEV GANTEN Director Emeritus President Max Planck Institute World Health Summit, for Infection Biology, Germany Germany

CARLOS SANTOS THOMAS METTENLEITER Chairman of the Board President of Directors Institute of Molecular Coimbra University Virology and Cell Biology, Hospital Center, Friedrich-Loe¾er-Institut, Portugal Germany 137

ELIZABETH BLACKBURN BEN CANNY THOMAS B. CUENI CHRISTIAN DROSTEN TARCÍSIO ELOY PESSOA Nobel Prize Laureate 2009, Former Head Director General Director DE BARROS FILHO President Emerita School of Medicine, International Federation Institute of Virology, Dean Salk Institute University of Tasmania, of Pharmaceutical Manu- Charité –Universitäts- Faculty of Medicine, for Biological Studies, Australia facturers & Associations medizin Berlin, University of São Paulo, USA (IFPMA), Switzerland Germany Brazil

EUGENIO GAUDIO CHARLES IBINGIRA ALI JAFARIAN MICHAEL J. KLAG BÄRBEL-MARIA KURTH Rector Principal Former Chancellor Former Dean Director Sapienza University Makerere University Tehran University Johns Hopkins Bloomberg Epidemiology and of Rome, College of Health Sciences, of Medical Sciences, School of Public Health, Health Monitoring, Italy Uganda Iran USA Robert Koch Institute, Germany

AXEL RADLACH PRIES MAIKE SANDER GÜNTER STOCK Dean Director President Charité –Universitäts- Pediatric Diabetes Research ALLEA – medizin Berlin, Center, UC San Diego, All European Academies, Germany USA Germany 138 WORLD HEALTH SUMMIT LEADERSHIP

COUNCIL

CO-CHAIRS MEMBERS

ALA ALWAN MANFRED DIETEL BÄRBEL KURTH University of Washington, Charité–Universitätsmedizin Robert Koch Institute Department of Global Health Berlin STEVE LANDRY RIFAT ATUN KLAUS DUGI Bill & Melinda Gates Foundation Harvard T.H. Chan School Ferring Pharmaceuticals of Public Health YVES LEVY TIMOTHY EVANS French Institute of Health TILL BÄRNIGHAUSEN World Bank and Medical Research Inserm ILONA KICKBUSCH Heidelberg University (until 2018) International Advisory ROLAND GÖHDE Board Chair GUNTHER BEGER GHA–German Health Alliance MARION LIESER Global Health Centre, German Federal Ministry Oxfam Germany Graduate Institute Geneva, Switzerland for Economic Cooperation JÖRG HACKER and Development German National Academy KLAUS LINDPAINTNER of Sciences Leopoldina InterVenn Biosciences INGO BEHNEL (until 2020) German Federal Ministry JÜRGEN MLYNEK of Health SHANNON HADER Falling Walls Foundation UNAIDS CHRISTOPH BEIER MATSHIDISO REBECCA MOETI Deutsche Gesellschaft für ANDREW HAINES World Health Organization Internationale Zusammenarbeit London School of Hygiene & Tropical Medicine BERND MONTAG CHRISTOPH BENN Siemens Healthineers ELHADJ AS SY Director Global Health ALEXANDER HEWER Chair Diplomacy, The Joep Lange Klinikum Stuttgart ANDREAS PENK Koﬁ Annan Foundation, Institute Pﬁzer Germany Switzerland ZSUZSANNA JAKAB TOBIAS BERGNER World Health Organization HAGEN PFUNDNER German Federal Foreign O±ce Roche Pharma AG ASHISH JHA ARNAUD BERNAERT Brown University PETER PIOT World Economic Forum London School of Hygiene STEFAN KAUFMANN and Tropical Medicine CATHERINA BÖHME Max Planck Institute Foundation for Innovative New for Infection Biology ERICH REINHARDT Diagnostics Medical Valley SUSANNA KRÜGER THOMAS B. CUENI Save the Children Germany Int. Federation of Pharma- ceutical Manufacturers & Associations (IFPMA) 139

AMBASSADORS

HEINZ RIEDERER iNG innovation. Nachhaltigkeit. Gesundheit

MAIKE RÖTTGER Association Development and Humanitarian Aid

EDELGARD BULMAHN MANFRED DIETEL ECKART VON MATTHIAS SCHELLER Former Federal Minister Former Director HIRSCHHAUSEN Albertinen-Diakoniewerk of Education and Research Institute of Pathology, Physician, Germany Charité–Universitäts- TV Host, Comedian HANS J. SCHELLNHUBER medizin Berlin, Germany Potsdam Institute for Germany Climate Impact Research (until 2018)

GÜNTER STOCK ALLEA–All European Academies

VERONIKA VON MESSLING German Federal Ministry of Education and Research MICHAEL RABBOW HEINZ RIEDERER REINHARD SCHÄFERS LOTHAR WIELER Senior Advisor Managing Director Former Ambassador Robert Koch Institute E&P Focus Africa iNG innovation. Federal Republic Consulting, Nachhaltigkeit. of Germany Germany Gesundheit, Germany

ANSGAR TIETMEYER CHARLES YANKAH Former Head Chairman of Public A£airs Afrika Kulturinstitut e.V., Deutsche Bank AG, Berlin, Germany Germany 140 M8 ALLIANCE LEADERSHIP

EXECUTIVE COMMITTEE

CHARLES IBINGIRA DETLEV GANTEN EUGENIO GAUDIO AXEL RADLACH PRIES International President Founding President International President 2022 Dean 2020 & 2021 World Health Summit Rector Charité – Universitäts - Principal Charité – Universitäts - Sapienza University of Rome, medizin Berlin, Makerere University medizin Berlin, Italy Germany College of Health Sciences, Germany Uganda

MICHAEL J. KLAG BEN CANNY ALI JAFARIAN TARCÍSIO ELOY PESSOA Former Dean Former Head Former Chancellor DE BARROS FILHO Johns Hopkins Bloomberg School of Medicine, Tehran University Dean School of Public Health, University of Tasmania, of Medical Sciences, Faculty of Medicine, USA Australia Iran University of Sao Paulo, Brazil 141

M8 ALLIANCE HEADS OF DELEGATION

Australia France Japan

CHRISTINA MITCHELL GÉRARD FRIEDLANDER SHUNICHI FUKUHARA Dean Dean Former Dean Monash University, Melbourne Faculty of Medicine, University School of Public Health, Kyoto University of Paris Descartes Brazil Portugal FRANÇOIS HOULLIER TARCÍSIO ELOY PESSOA Acting President AMÍLCAR FALCÃO DE BARROS FILHO Université Sorbonne Paris Cité Rector Dean University of Coimbra Faculty of Medicine, University of Sao Paulo Germany DUARTE NUNO VIEIRA EDUARDO KRIEGER HEYO KROEMER Dean Former President Chief Executive O±cer Faculty of Medicine, University of Coimbra Brazilian Academy of Sciences Charité – Universitätsmedizin Berlin Russian Federation Canada AXEL RADLACH PRIES Dean IVAN DEDOV PATRICK COSSETTE Charité – Universitätsmedizin Berlin President Dean Russian Academy of Medical Sciences Faculty of Medicine, University of Montreal Iran EVGENY SIDORENKO MAX FEHLMANN ALI JAFARIAN Vice-President President and Scientiﬁc Director Former Chancellor Russian Academy of Medical Sciences Montreal Clinical Research Institute Tehran University of Medical Sciences Singapore China AMIRHOSSEIN TAKIAN Chair JOHN EU-LI WONG XUETAO CAO Department of Global Health Chief Executive O±cer President and Public Policy, Tehran University National University Health System Chinese Academy of Medical Sciences& of Medical Sciences Peking Union Medical College KHAY GUAN YEOH Italy Dean DEPEI LIU Yong Loo Lin School of Medicine, Co-Chair EUGENIO GAUDIO National University of Singapore InterAcademy Partnership (IAP) Rector Sapienza University of Rome TEO YIK YING Vice-Dean (Research) LUCIANO SASO Saw Swee Hock School of Public Health Vice-Rector for European National University of Singapore University Networks Sapienza University 142 M8 ALLIANCE LEADERSHIP

Switzerland Uganda International Associations

ANTOINE FLAHAULT CHARLES IBINGIRA STEVEN L. KANTER Director Principal President & CEO Institute of Global Health Makerere University Association of Academic Health Centers College of Health Sciences (AAHC) CEM GABAY Dean United Kingdom ANN KURTH Faculty of Medicine, University of Geneva Chair DEBORAH ASHBY Consortium of Universities for Global Health BERTRAND LEVRAT Director of the School of Public Health (CUGH) Chief Executive O±cer Imperial College London Geneva University Hospitals LEONEL VALDIVIA PETER PIOT President VINH-KIM NGUYEN Director World Federation of Academic Director London School of Hygiene & Institutions for Global Health (WFAIGH) Global Health Center, Tropical Medicine The Graduate Institute Geneva Individual Members USA NICOLE ROSSET RIFAT ATUN Deputy Director ADNAN HYDER Director Geneva University Hospitals (HUG), Senior Associate Dean for Research Global Health Systems Cluster, External A£airs and Executive Milken Institute School of Public Health Harvard T.H. Chan School of Public Health, Management Member at George Washington University USA

Taiwan MICHAEL J. KLAG BEN CANNY Former Dean Former Head CHANG-CHUAN CHAN Johns Hopkins Bloomberg School of Medicine, University of Tasmania, Associate Dean School of Public Health, Baltimore Australia National Taiwan University ELLEN MACKENZIE Turkey Dean Johns Hopkins Bloomberg MAHMUT AK School of Public Health, Baltimore Rector Istanbul University

BAHAÜDDIN ÇOLAKOGLU Dean Istanbul University, Faculty of Medicine SPEAKERS INDEX 143

A D Abdi, Omar 109 Blohmer, Martin 77 Dalil, Suraya 101 Fore, Henrietta H. 129 Abdullah, Khairul 75 Bloom, Theodora 39 Davies, Dame Sally 25,55 Forland, Frode 71 Abubakar, Ibrahim 111 Boehme, Catharina Debré, Patrice 49 Foster, Juliette 61 Addo, Marylyn 85 29,49,79 Degos, Laurent 125 Frieden, Tom 79 Adewara, Funmi 93 Bonefeld-Dahl, Cecilia 69 De Paula, Nicole 77 Frohlo£, Astrid 87 Adeyeye, Moji Christianah 115 Bönig, Constanze 83 de Szolnok, Jean Scheftsik 65 Adomakoh, Nicholas 23 Brakhage, Axel 73 de Witte, Bart 21 G Aerts, Ann 105 Brooks, Steve 25 Dhatt, Roopa 99 Gabrysch, Sabine 59,89 Agbega, Christopher 93 Bruchhausen, Walter 63 Dirnagl, Ulrich 21,39 Gantar, Tomaž 67 Agyeman-Manu, Kwaku 101 Bulmahn, Edelgard 95 Dong, Xiaoping 109 Ganten, Detlev 47,51 Ahmed, Monir 127 Buyx, Alena 21 Doole, Claire 23 Gao, George F. 31,123 Ali, Hera 77 Byanyima, Winnie 45,51 Doyle, Yvonne 71 Garcia-Moreno, Claudia Allotey, Pascale 119 Draghia-Akli, Ruxandra 43 119 Ammon, Andrea 31,41,117 C Drosten, Christian Garms, Thomas 25 Amuasi, John 65,85,89 Cale±, Maira 69 71,79,107,125 Gastmeier, Petra 73 Annen, Niels 59 Campbell, Jim 33 Dzau, Victor J. 43 Gaudry-Perkins, Florence Ashing, Inger 121 Campe, Sabine 29 123 Asiedu-Bekoe, Franklin 27 Capobianco, Emanuele 109 E George, Asha 119 Ayakaka, Irene 83 Capon, Tony 89 Ehlers, Stefan 85 Gerhardt, Holger 105 Azadzoy, Hila 45 Chan, Chang-Chuan 57 Elfadil, H.E. Amira Elfadil Germann, Stefan 35 Chan, Margaret 57,99 Mohammed 61 Ghebreyesus, Tedros B Charmeil, Olivier 41 Eloit, Monique 107 Adhanom 51,55,129 Bachelet, Michelle 121 Chataway, Mark 41 El Omrani, Omnia 77 Ghosh, Shiulie 69 Balaji, Lakshmi Narasimhan 37 Chopra, Supriya 81 Enany, Shymaa 77,127 Gilhooly, Denis 123 Balasegaram, Manica 23 Cocero, Nanette 51 Gill, Amandeep Singh 55 Baptista Leite, Ricardo 21,45,93 Collins, Sir Rory Edwards F Göhde, Roland 45 Baum, Christopher 39 105 Farrar, Jeremy 129 Goldacre, Ben 39 Bendhaou, Karim 115 Colombo, Francesca Fatmawati, Sri 127 Gore, Charles 103 Berankytė, Ieva 77 21,47,87,99 Fears, Robin 75 Gostin, Lawrence O. 35 Berkley, Seth 121 Cooke, Graham 103 Fisher, Dale Andrew 109 Graham, Teresa 69,113 Bethell of Romford, Lord 87 Costa, Alex 23 Fitchet, Martin 57 Grossi, Rafael Mariano Beyer, Peter 25 Cubelo, Floro 33 Flachsbarth, Maria 81,121 Bhola, Mukul 61 Cueni, Thomas 79,87 65,107,117 Guterres, António 51 144 SPEAKERS INDEX

H Hader, Shannon 113 Kaufmann, Stefan H.E. 43,85 Mettenleiter, Thomas C. Ohnesorge, Bernd 123 Haines, Sir Andrew 59,75 Kayumba, Pierre Claver 115 73,107 Oni, Tolullah 37,95 Hanefeld, Johanna 63,109 Kennedy, Annette 33 Mikkelsen, Bente 61,93 Ozawa, Sachiko 115 Harrison, Jim 91 Kerouedan, Dominique 111 Miller, Jeni 59 Hatchett, Richard 43 Kickbusch, Ilona 31,67,129 Miribel, Benoît 47 P Haug, Gerald 89 Kieny, Marie-Paule 37 Mohammed, Bello Abubakar Palkonen, Susanna 125 Heide, Lutz 115 Kinnair, Dame Donna 33 81 Pate, Muhammad 129 Heyder, Ralf 49 Klapper, Bernadette 37 Montag, Bernd 35 Pickel, Birgit 63 Hillware, Sarah 99 Köhler, Carsten 83 Monti, Roberto Francesco Piot, Peter 79 Hofstraat, Hans 125 Kohler, Stefan 127 95 Piyawattanametha, Hörauf, Achim 63,83 Krause, Gérard 27 Muhsin, Muhsinzoda Gafur Wibool 127 Htwe, H.E. Myint 61 Kurzai, Oliver 73 101 Portella, Gina 105 Hudson, Paul 51 Kyriakides, Stella 55 Müller, Gerd 107,117 Pulcini, Céline 25 Huxley, Rachel 59 Müller, Jürgen 41 Hyder, Adnan A. 57 L Mundani, Dagmar 21 R Langenbucher, Anja 113 Mundel, Trevor 43 Rehfuess, Eva 71 I Larsson, Joakim 25 Murenga, Maurine 103 Reis, Andreas Alois 39 Ibbotson, Geo£rey 91 Leitner, Carl 27 Reitenbach, Dagmar 23 Ibingira, Charles 51 Liu, Depei 43 N Renshaw, Nina 93 Iro, Elizabeth 33 Lodunu-Senoo, Cecilia 101 Neci, Richard 115 Reynolds, Teri 91 Islam, Abul Bashar Mir Md Logora, Makoy Yibi 83 Neumaier, Michael 21 Roche, Benjamin 89 Khademul 127 Lucchini, Marc-Antoine 93 Ngamije, H.E. Daniel 61 Røttingen, John-Arne 125 Iyer, Jayasree K. 29,79,103 Nimmesgern, Elmar 23 Rupp, Jochen 49 M Nkengasong, John 31,117 Ryan, Michael 109 J Malecela, Mwelecele Ntuli 83 Nobre, Carlos A. 59 Jafarian, Ali 91 Mariano Jr., Bernardo 35,55 Nsiah-Asare, Anthony 65 S Janušonytė, Eglė 77 Martin, Rebecca 109 Nur, Fawziya Abikar 101 Sabino, Ester Cedeira 99 Jinks, Tim 87 Mattar, Caline 77 Nurse, Joanna 57 Saﬁ, Malik Muhammad 101 Johansson, Ylva 111 McNeill, Jeremy 75 Sall, Amadou 109 Meara, John G. 91 O Samad, Lubna 91 K Mehnert, Anja 69 Obiero, Christina 23 Samiya, Aishath 55 Kanem, Natalia 121 Ménard, Joël 105 O’Brien, Joann 123 Sands, Peter 129 Katuta, Hon. Given 45 Mestres, Isabel 69 Oelrich, Stefan 87 Santos, Clara Cruz 95 SPEAKERS INDEX 145

Saso, Luciano 111 Streeck, Hendrik 45 von Kalle, Christof 49 Schmid, Peter 73 Subash, Arya Shalini 127 von Messling, Veronika 29 Schmitt, Tugce 77 Sunder, Wolfgang 73 Vorisek, Dana 47 Schmutte, Caroline 63 Swaminathan, Soumya Voss, Maike 71 Schwartländer, Bernhard 43,55,71,117,123 67,121 Sy, Elhadj As 99,117 W Seeberger, Peter H. 49 Szlamka, Zsóﬁa 77 Waltz, Johannes 83 Sehouli, Jalid 113 Waqainabete, H.E. Ifereimi 91 Seita, Akihiro 111 T Wenham, Clare 99 Seraﬁni, Micaela 109 Takian, Amirhossein 57 Were, Miriam K. 55 Severoni, Santino 111 Tanden, Neera 95 Wieler, Lothar H. 31,41,65,73 Seydoux, Stéphanie 31 Temido, Marta 67 Wilson, Dow R. 81 Shah, Rajiv 55 ter Meulen, Volker 75 Winkler, Andrea 65,89 Shaikh, Mujaheed 37 Torode, Julie 81 Witty, Sir Andrew 29 Sillanaukee, Päivi 35 Touraine, Marisol 103,129 Wright, Caradee 75 Simão, Mariângela 103 Simelela, Princess Nothemba U Z 113,119 Ullmann, Andrew 45 Zou’bi, Moneef R. 95 Simón, Fernando 71 Ullrich, Andreas 113 Simpson, Paul 119 Singh, Paramdeep 127 V Sinkins, Steven 85 Vaïsse, Justin 95 Sipido, Karin R. 125 Vayena, E£y 35 Sliwa-Hahnle, Karen 105 Vehviläinen-Julkunen, Katri Snower, Dennis J. 47 33 Sørensen, Kristin 37 Velaphi, Sithembiso 23 Soucat, Agnés 47 Velazquez, Daniel De Jesus Spahn, Jens 67 Limonta 127 Starke, Dagmar 27 Véran, Olivier 41 Steinmeier, Frank-Walter 51 Vijayasingham, Lavanya 119 Sto£els, Paul 29 Vives, Lauro 27 Stoltenberg, Camilla 65 von Baumbach, Hubertus 61 Strech, Daniel 39 von der Leyen, Ursula 51 146 INSTITUTIONS INDEX

A AO Alliance Foundation 90 German Society for Tropical Medicine and Association of Academies and Societies of Sciences International Health (DTG) 82 in Asia (AASSA) 74 Germany’s Presidency of the Council Association of Research-based Pharmaceutical of the European Union 66 Companies (vfa) 82,114 GHA–German Health Alliance 44 Global Antibiotic Research & Development Partnership B (GARDP) 22 Berlin Institute of Health (BIH) 38,48 Global He@lth 2030 Innovation Task Force 122 Boehringer Ingelheim Pharma GmbH & Co.KG 60 Global Outbreak Alert and Response Network (GOARN) 108 C Global Solutions Initiative 46 Charité – Universitätsmedizin Berlin 38,42,78,112,124 Global Young Academy (GYA) 126

E H Eberhard Karls University Tuebingen 82 Helmholtz Centre for Infection Research (HZI) 26

F I Fondation Botnar 34 InfectControl 72 Foundation for Innovative New Diagnostics (FIND) 78 InterAcademy Partnership (IAP) 74,88,94 Inter-American Network of Academies of Science G (IANAS) 74 German Alliance for Global Health Research 70 International Atomic Energy Agency (IAEA) 80 German Federal Ministry for Economic Cooperation International Federation of Medical Students’ Associations and Development (BMZ) 64,106,116 (IFMSA) 76 German Federal Ministry for Economic A£airs International Federation of Pharmaceutical and Energy (BMWi) 114 Manufacturers & Associations (IFPMA) 86 German Federal Ministry of Education and Research (BMBF) 62,70,72 J German Federal Ministry of Health (BMG) Johnson & Johnson 28 66,100,120,128 German National Academy of Sciences Leopoldina L 88 Leibniz Association 84 German Network against Neglected Tropical Diseases London School of Hygiene & Tropical Medicine (LSHTM) (DNTDs) 82 58,78 INSTITUTIONS INDEX 147

M T M8 Alliance 30,50,56,58,78,94,110,112,124 Tehran University of Medical Sciences (TUMS) 56 Max Delbrück Center for Molecular Medicine (MDC) 104 The BMJ 118 Max Planck Institute for Infection Biology 42 The Defeat-NCD Partnership 60 Medicines Patent Pool (MPP) 102 The George Washington University, Milken Institute School Milken Institute School of Public Health 56 of Public Health 56 The Graduate Institute of International N and Development Studies 30 NCD Alliance 92 The Lancet One Health Commission 64,88 The Network of African Science Academies (NASAC) 74 P Program in Global Surgery and Social Change U of the Harvard Medical School 90 UNAIDS 44 UNITE 44 Q University Hospital Tuebingen 82 QUEST Center 38 University of Eastern Finland 32 UNU International Institute for Global Health (UNU-IIGH) 118 R Research Center Borstel – Leibniz Lung Center 84 V Robert Bosch Foundation 36 Varian Medical Systems 80 Robert Koch Institute (RKI) 108 Roche 68 W Women in Global Health 98 S World Health Organization (WHO) 24,54,100,108,118,120,128 Sanoﬁ 40,92 World Health Summit 50 Sapienza University of Rome 110 Siemens Healthineers AG 20 148 PARTNERS

SPONSORING PARTNERS

Strategic Partners

Major Partners Gerneral Partners PARTNERS 149

SUPPORTING PARTNERS

SERVICE PARTNERS 150 PARTNERS

POLICY MAKERS

ACADEMIA PARTNERS 151

CIVIL SOCIETY

H E E M C O L R UB OF SCHOOL 152 PARTNERS

ASSOCIATES

Digital Health

MEDIA PARTNERS

In Zusammenarbeit mit: Polish Healthcare Journal

Ogólnopolski System Ochrony Zdrowia WORLD HEALTH SUMMIT OFFICE 153

President Director of Operations Detlev Ganten Petra Neitzel

Managing Director Strategic Partnerships Ocer Jörg Heldmann Lukas Pfannenschmidt

Program Director Media Assistant Julian Kickbusch Frederike Sontag WHS Foundation GmbH Strategic Communications Content Assistant c/o Charité–Universitätsmedizin Berlin Director Alida Tiekötter Charitéplatz 1 Daniela Levy 10117 Berlin PA to the President Germany Director of Pascale Schulte International Cooperations Tel.: +49 30 450 572102 Oce Manager Nora Anton Fax: +49 30 450 572911 Martin Liedtke Political Advisor [email protected] Trainee Reinhard Schäfers www.worldhealthsummit.org Wim Stavginski

The World Health Summit is organized in cooperation with: With support from: 154 NOTES NOTES 155 156 IMPRINT

Photo Credits

Addo, Marylyn | Page 85¦© C.D. Ketels Mundani, Dagmar | Page 21¦© W.Geyer Bachelet, Michelle | Page 121¦© UN Photo-Manuel Elias Oelrich, Stefan | Page 87¦© fotomanufaktur schnittﬁncke Balasegaram, Manica | Page 23¦© Laurent Egli Ohnesorge, Bernd | Page 123¦© Ste£en Kirschner/Viaframe Bethell of Romford, Lord | Page 87¦© Roger Harris Photographie Ozawa, Sachiko | Page 115¦© will kirk/the johns hopkins university Beyer, Peter | Page 25¦© Sunanda Deshapriya Portella, Gennarina | Page 105¦© Gianluca Cecere Bloom, Theodora | Page 39¦© Philippa Gedge, 2017 Rehfuess, Eva | Page 71¦© Norman Pretschner Bulmahn, Edelgard | Page 95, 139¦© Deutscher Bundestag Sands, Peter | Page 129¦© The Global Fund/Vincent Becker Capon, Tony | Page 89¦© The University of Sydney/Louise M. Cooper Saso-Luciano | Page 111¦© stephenbusuttil.com Charmeil, Oliver | Page 41¦© Peter Allan Schmutte, Caroline | Page 63¦© Bernhardt Link/Farbtonwerk Cocero, Nanette | Page 51¦© 2015, Wendy Barrows Sehouli, Jalid | Page 113¦© Wiebke Peitz Colombo, Francesca | Page 21, 87, 99¦© OECD/Andrew Wheeler Seydoux, Stéphanie | Page 31¦© Judith Litvine Degos, Laurent | Page 125¦© Laurent Hou Shaikh, Mujaheed | Page 37¦© Vincent Mosch Dirnagl, Ulrich | Page 21, 39¦© BIH/Thomas Rafalzyk Sto£els, Paul | Page 29¦© A.E. Fletcher Photography Doyle, Yvonne | Page 71¦© Greater London Authority Stoltenberg, Camilla | Page 65¦© Marius Tharaldsen Draghia-Akli, Ruxandra | Page 43¦© Merck & Co., Inc Touraine, Marisol | Page 103, 129¦© Elodie Grégoire Drosten, Christian | Page 71, 79, 107, 125, 137¦© Wiebke Peitz Véran, Olivier | Page 41¦© Ministeres Sociaux/DICOM/ Eloit, Monique | Page 107¦© Maurine Tric Nicolo Revelli Beaumont/SIPA PRESS Flachsbarth, Maria | Page 65, 107, 117¦© Thomas Trutschel/photothek.net von Hirschhausen, Eckart | Page 139¦© Camillo Wiz Fore, Henrietta | Page 129¦© UNICEF-UN0154449-Nesbitt Gantar, Tomaz | Page 67¦© Bor Slana/STA Delphi-Saal | Page 134¦© visitBerlin, Foto: Peter Gesierich Gastmeier, Petra | Page 73¦© Wiebke Peitz Humboldtforum | Page 134¦© SHF/visitBerlin, Foto: Stephan Falk Gore, Charles | Page 103¦© CAP PHOTO Panorama Berlin | Page 135¦© visitBerlin, Foto: Wolfgang Scholvien Grossi, Rafael Mariano | Page 81, 121¦© Dean Calma Guterres, António | Page 51¦© UN Photo/Mark Garten Heyder, Ralf | Page 49¦© Wiebke PeitzI/Charité Universitätsmedizin Berlin Layout Iyer, Jayasree | Page 29, 79, 103¦© www.patriciawolf.nl Eta Friedrich, Berlin Kieny, Marie-Paule | Page 37¦© Inserm/Patrick Delapierre Klapper, Bernadette | Page 37¦© www.michaelfuchs-fotograﬁe.de Printer Köhler, Carsten | Page 83¦© UKT Spree Druck, Berlin Kurth, Bärbel-Maria | Page 137¦© Robert Koch-Institut/Dugnus Kurzai, Oliver | Page 73¦© Anna Schroll Kyriakides, Stella | Page 55¦© EU Merkel, Angela | Page 8¦© Bundesregierung/S. Kugler Mettenleiter, Thomas | Page 73, 107¦© Wolfram Maginot Müller, Jürgen | Page 41¦© Kay Herschelmann Muhsin, Muhsinzoda Gafur | Page 101¦© Ruziev World Health Summit

WHS Foundation GmbH c / o Charité – Universitätsmedizin Berlin Charitéplatz 1 10117 Berlin Germany

Tel.: +49 30 450 572102 Fax: +49 30 450 572911

[email protected] www.worldhealthsummit.org SAVE THE DATES

WORLD HEALTH SUMMIT REGIONAL MEETING AFRICA

KAMPALA, UGANDA JUNE 27–30, 2021

WORLD HEALTH SUMMIT

BERLIN, GERMANY OCTOBER 24–26, 2021